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1. Introduction 
1.1 Distal Convoluted Tubule 
The kidney plays an important role in maintaining body electrolytes and fluid balance, blood 
pressure and in the regulation and maintenance of systemic acid-base balance. The 
nephron is the structural and functional unity of the kidney (Figure 1). This functional unit 
filters the blood, reabsorbs the filtered electrolytes, solutes and fluid and excretes excessive 
electrolytes and water.1 
 
Figure 1. Schematic representation of a single nephron. 
The nephron is the microscopic structural and functional unit of the kidney. It is composed of a renal 
corpuscle and a renal tubule. In the glomerulus, ultra-filtrate is continuously generated by filtration of 
the blood. In the adherent renal tubule, certain substances and water are either reabsorbed or 
secreted. The ultra-filtrate first reaches the proximal tubule―the main side of reabsorption―followed 
by the U-shaped loop of Henle including the thick ascending limb, where the filtrate is concentrated. 
Fine-tuning of the urine composition takes place in the distal convoluted tubule (red) and in the 
collecting ducts. 
The distal convoluted tubule (DCT) is the shortest segment of the nephron and is the portion 
of the nephron that is immediately downstream from macula densa and ends in the 
connecting tubule/collecting duct system (CD). Despite its size, DCT plays an important role 
in regulating the extracellular fluid volume and electrolyte homeostasis in a variety of 
homeostatic processes that include sodium (Na+) reabsorption, potassium (K+) secretion, 
calcium (Ca2+) and magnesium (Mg2+) handling (Figure 2). The DCT can be further divided 
into two sub-segments, DCT1 and DCT2, which are distinguished by their response to the 
mineralocorticoid aldosterone. Aldosterone is a steroid hormone that is released from the 
adrenal glands in response to hyperkalemia and volume depletion. DCT2 is more sensitive 
to aldosterone due to the expression of an enzyme called 11-β hydroxysteroid 
dehydrogenase 2 (11-βHSD2) that metabolizes cortisol. Cortisol has a structure similar to 
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aldosterone, therefore by metabolizing cortisol to cortisone the enzyme 11-βHSD2 prevents 
the binding to the mineralocorticoid receptor expressed in the DCT2. The enzyme 11-
βHSD2 is also expressed in connecting tubule (CNT) and CCD making these three 
segments known as the aldosterone sensitive distal nephron.2,3,4,5,6  
DCT is morphologically unique since its extensive basolateral membrane has numerous 
deep infoldings and the cells are particularly rich in mitochondria. Because of very high rates 
of transcellular ion transport, the DCT requires a considerable amount of ATP high activity 
of Na+/K+-ATPase to maintain ionic gradients. It is therefore, not surprising that DCT cells 
possess the highest density of Na+/K+-ATPase along the nephron.7,8 
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Figure 2. Schematic model of distal convoluted tubule and connecting tubule. 
In the early DCT (DCT1), apical Na+ reabsorption is exclusively mediated by NCC, whereas in the 
late DCT (DCT2) and connecting tubule (CNT). Na+ reabsorption is also mediated by the epithelial 
Na+ channel ENaC. Na+ transport by ENaC is coupled to the activity of the renal outer medullary K+ 
channel (ROMK) mediating K+ secretion into the urine. The Na+/K+-ATPase mediates basolateral 
Na+ efflux and K+ uptake. The latter is functionally coupled to K+ recycling through Kir4.1-Kir5.1. 
Apical Ca2+ transport is mediated by TRPV5 in the late DCT and connecting tubule. In the cytosol, 
Ca2+ is bound by calbindin and then transported out of the cell by NCX1 or plasma membrane Ca2+ 
ATPases (PMCA). 
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1.1.1 Reabsorption of Na+ in the DCT 
Regulation of Na+ excretion is essential to control and maintenance of extracellular fluid 
balance and blood pressure control. Na+ is mainly reabsorbed by proximal tubules (PT) and 
thick ascending limbs (TAL) with fine-tuning occurring in the distal convoluted tubule (DCT), 
connecting tubule (CNT) and collecting ducts (CD). The DCT cells are responsible for 
reabsorbing 5-10% of the filtered Na+ and chloride (Cl-) from the filtrate. The uptake of Na+ 
in the DCT is mediated through the action of the NaCl cotransporter (NCC). NCC, also 
known as thiazide-sensitive Na+ and Cl- cotransporter, is localized in the apical membrane 
of DCT1. This process is electroneutral, since for one Na+ cation one Cl- anion enters the 
cell. NCC inhibition by thiazides, a class of diuretics, is used in the clinical setting for the 
treatment of arterial hypertension and edema. Thiazides inhibit Na+ reabsorption by 
blocking NCC thereby decreasing the workload for the Na+/K+-ATPase. In parallel, urinary 
Na+, K+ and Mg2+ excretion increases. However, Ca2+ is less excreted (hypocalciuria). 
Hypocalciuria was postulated to be generated by two different mechanisms: either by 
increased active Ca2+ uptake via the vanilloid transient receptor potential channel 5 
(TRPV5) in the DCT, or by thiazide-induced hypovolemia resulting in enhanced passive 
Ca2+ uptake in the proximal convoluted tubule.9 Since the TRPV5-/- mice still developed 
hypocalciuria when given thiazide diuretics, an increased uptake of Ca2+ in the DCT seems 
less likely.2,9–14 
Besides Na+ uptake through NCC, Na+ can also be taken up in DCT2 by the amiloride-
sensitive epithelium Na+ channel (ENaC). ENaC, mediates Na+ influx and causes a 
depolarization of the apical membrane. This depolarization enhances the driving force for 
K+ secretion across the apical membrane through the "renal outer medullary K+ channel" 
(ROMK). The reabsorbed Na+ is extruded at the basolateral side by the Na+/K+-ATPase. 
The activity of the Na+/K+-ATPase fuels further Na+ transport across the tubular cells by 
keeping the intracellular Na+ concentration low and the K+ concentration high (Figure 2). 6,15 
1.1.2 Regulation of DCT K+ transport 
As mentioned above, sustained reabsorption of Na+ by either NCC or ENaC requires 
basolateral Na+ extrusion via the Na+/K+-ATPase. For ongoing activity of Na+/K+-ATPase, 
that exchanges three Na+ for two K+, the basolateral availability of K+ can become a limiting 
factor, especially at high transport rates and when the basolateral space is narrow, i.e. in 
the basolateral infoldings of the plasma membrane. Therefore, basolateral K+ channels 
serve two important functions: i) they hyperpolarize the membrane (which is important for 
voltage-dependent processes such as Cl- exit through channels) and ii) the recycle of K+ 
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thereby allowing the ATPase to run at high transport rates. The functional coupling of the 
ATPase and the basolateral K+ conductance (K+ leak) is called "pump-leak coupling".2,6,8,16 
Recently, a more prominent role of the DCT in the regulation of K+ homeostasis was 
suggested by Terker and co-workers.17 They hypothesized that DCT cells can actively 
sense changes in plasma [K+] and indirectly modify K+ secretion in CNT and CCD through 
regulation of the NCC. Reduced NCC activity leads to an enhanced Na+ flux to CNT and 
CCD where Na+ is then replaced by K+. They suggested, that the plasma K+ sensor Kir4.1 
(and Kir4.1-Kir5.1) that senses increases in plasma [K+] by translating it into a depolarization 
of DCT cells. This depolarization, in turn results in increased intracellular [Cl-] by reducing 
the driving force for Cl- efflux via ClCKb channels. Increased intracellular [Cl-] then was 
proposed to lead a decrease in phosphorylation of NCC via the inhibition of the Cl--sensitive 
WNK-SPAK/OSR1 kinase pathway ultimately leading to decreased Na+ reabsorption in the 
early DCT (Figure 3).17,18 The resulting elevated luminal Na+ ions would be reabsorbed in 
more distal segments via ENaC leading to ROMK-mediated secretion of K+ and 
normalization of elevated plasma K+ levels.  
Narrow regulation of plasma K+ between 3-6 mM concentrations is vital for life. Depending 
on plasma K+ levels, the kidney can vary the fraction excretion of K+ from 1% (net 
reabsorption) to 200% (net secretion) meaning that the kidney is a main contributor to K+ 
homeostasis. This flexibility is a property of the aldosterone-sensitive distal nephron 
including collecting ducts. In the early DCT, secretion of K+ is low and increases along the 
distal tubule parallel to the increase in lumen-negative transepithelial voltage observed in 
the late DCT. ROMK mediated K+ transport depends on the driving force for K+ secretion 
which is mainly determined by the aldosterone-regulated ENaC-mediated Na+ reabsorption. 
The increased activity of ENaC depolarizes the apical membrane, which is a stimulus for K+ 
efflux through ROMK. Other channels may be involved in K+ secretion Maxi-K+ channels 
(BK channels). BK channels are triggered in states of high urinary flow (during diuretic use, 
for example) leading to an increase of K+ secretion under these conditions.2,5,19 
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Figure 3. Model of K+ sensing and regulation in the distal tubules. 
In the distal convoluted tubule DCT, elevated plasma K+ levels are sensed by heteromeric Kir4.1-
Kir5.1 channels leading to depolarization of the basolateral membrane potential (Vm), which in turn 
inhibits Cl- efflux via ClCKB channels. The resulting increased intracellular [Cl-] blocks the Cl--
dependent kinases in the WNK/SPAK pathway, which in turn inhibits the activity of the Na+/Cl--
cotransporter (NCC) resulting in elevated luminal Na+ levels. Apical Na+ is reabsorbed in the more 
distal connecting tubule (CNT) and collecting duct (CD) by the epithelial Na+ channel (ENaC) 
ultimately leading to K+ efflux via the renal outer medullary K+ channel (ROMK) effectively correcting 
the elevated plasma K+ levels.  
1.1.3 Ca2+ reabsorption in the DCT 
Extracellular Ca2+ is tightly regulated and serves as intracellular messenger in numerous 
essential cellular events such as immune response, muscle contraction, hormone secretion 
and regulation of enzymes. Ca2+ is regulated in the renal tubules by several calciotropic 
hormones including parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3 (vitamin D3), 
calcitonin and Ca2+ itself. PTH and vitamin D3 are known to increase Ca2+ reabsorption in 
TAL, DCT and CNT. Plasma Ca2+ also controls renal Ca2+ absorption through altered PTH 
secretion and by binding to the Ca2+-sensing receptor (CaSR) in the TAL. To facilitate 
paracellular Ca2+ reabsorption along renal tubules, transepithelial voltage difference needs 
to be favorable paracellular Ca2+ passage, meaning a positive voltage in the apical side. 
For transcellular reabsorption, Ca2+ can enter through apical channels and needs to be 
extruded in an energy consuming process on the basolateral side.9,20–22  
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In the kidney, transcellular Ca2+ reabsorption is restricted to the late DCT and CNT. Only 5-
10% of filtered Ca2+ is absorbed in DCT in a three-step process. In the DCT, the transport 
of Ca2+ is passively mediated by TRPV5 channels on the apical membrane. The reabsorbed 
Ca2+ is then bound to cytosolic calbindin-D28K, which is involved in transcellular Ca2+ 
diffusion and buffers cytosolic Ca2+ to maintain a low intracellular concentration. Ca2+ then 
is basolaterally extruded by secondary active transport through Na+ /Ca2+ exchanger (NCX1) 
and across Ca2+-ATPase (PMCA 1-4). NCX1 controls intracellular Ca2+ levels by extruding 
Ca2+ from the cell. In the kidney, NCX1 is expressed in the basolateral membrane of DCT2 
and CNT and actively transport Ca2+ back to basolateral side due to electrochemical 
gradient created by Na+/K+-ATPase playing a key role in the process of renal transcellular 
Ca2+ reabsorption.10,12,20,23,24  
1.2 DCT disorders 
Mutations in renal ion transport systems can lead to distinct salt-losing nephropathies, which 
demonstrate the kidneys’ crucial role in fluid and electrolyte homeostasis. 
1.2.1 Gitelman’s syndrome 
Gitelman’s syndrome mimics the effect of long-term thiazide treatment and is an autosomal 
recessive salt-wasting kidney disease characterized by hypokalemia, hypomagnesemia, 
decrease of Ca2+ in urine and elevated blood pH (metabolic alkalosis). The disorder is 
caused by genetic mutations resulting in improper function of the thiazide-sensitive NCC in 
the DCT.6,10 In more than 80% of the cases, Gitelman’s syndrome can be linked to 
inactivating mutations in SLC12A3 that encodes the NCC. Due to inactivation of the NCC, 
the reabsorption of Na+, Cl- and Mg2+ is reduced in the DCT while proximal Ca2+ 
reabsorption is increased as discussed earlier (Section 1.1.1).13,25 The CNT and CD 
compensate the loss of Na+ by activation of ENaC to some extend leading to secretion of 
K+ and H+. Ultimately, Na+, K+, H+, Mg2+ and Cl- are wasted into the urine leading to the 
above-mentioned symptoms of hypokalemia, hypomagnesemia, hypocalciuria and 
alkalosis. Additionally, the loss of Na+ leads to hypovolemia with secondary increased 
aldosterone levels. 3,13,26,27 
1.2.2 Familial hyperkalemic hypertension (Gordon syndrome) 
Familial hyperkalemic hypertension (FHHt) is a rare monogenic hypertensive disease also 
called pseudohypoaldosteronism type II. FHHt results from mutations in the genes encoding 
the WNK kinases (serine/threonine kinases) or regulatory proteins and is characterized by 
hyperkalemia and hypertension and hyperchloremic metabolic acidosis.28,29 The common 
result of all mutations is the modulation of NCC activity. For example, WNK4 inhibits the 
Introduction 
-11- 
 
activity of NCC, while mutations in SPAK and OSR1 activate those kinases, which results 
in phosphorylation and activation of the NCC and other cotransporters, thereby increasing 
Na+ reabsorption and K+ secretion by ROMK. However, other WNK4 mutation can have a 
stimulatory effect on NCC by reducing its inhibitory effect on NCC trafficking and increasing 
NCC surface expression (Figure 3). Another kinase, WNK1 can inhibit wildtype WNK4 and 
activate SPAK and OSR1 stimulating NCC surface delivery and phosphorylation.2,5,18,28  
Recent models suggests that the DCT senses changes in plasma [K+] that affects NCC 
activity. Increases in plasma [K+] depolarizes the basolateral membrane, which leads to an 
increase of intracellular [Cl-]. Afterwards, Cl- binds to WNK kinases decreasing 
phosphorylation of NCC and therefore impairing NCC activity.18,26  
1.2.3 EAST/SeSAME syndrome 
To date, EAST/SeSAME syndrome is the only clinical distal tubular disorder known to affect 
a basolateral K+ channel. Multiple loss-of-function mutations of KCNJ10 were found to 
cause EAST/SeSAME syndrome. The electrophysiological consequences of over 120 
coding-region single nucleotide polymorphisms (SNPs) reported in publicly accessible 
genome databases still remain to be examined.2,30,31 
The medical relevance is underlined by the pathophysiology of the EAST/SeSAME 
syndrome, a disorder in which an inwardly rectifying K+ channel causes a hereditary form 
of renal salt wasting tubulopathy. The tubulopathy is characterized by hypokalemia, 
metabolic alkalosis, hypomagnesemia and hypocalciuria ‒ a pattern reminiscent of the 
symptoms in Gitelman’s syndrome. In contrast to Gitelman's syndrome, in which only the 
kidneys are affected, the EAST/SeSAME syndrome is a pleiotropic disease. The acronym 
“EAST” stands for epilepsy, ataxia, sensorineural deafness and tubulopathy. The acronym 
“SeSAME” stands for seizures, sensorineural deafness, ataxia, mental retardation and 
electrolyte imbalance. Both acronyms refer to the same genetic disease and are caused by 
loss-of-function mutations of Kir4.1 (encoded by the KCNJ10 gene). 
Kir4.1 is a basolateral K+ channel in DCT, CNT and cortical CD. The disease-causing 
mutations diminish or completely abolish its function and, therefore impair transcellular 
electrolyte transport in those nephron segments. 16,30,32–37 
1.3 Classification and function of K+ channels 
K+ channels are located in most cell membranes and control transportation of K+ ions efflux 
from and influx into cells. They play crucial roles in excitable and non-excitable cells. K+ 
channels have two to six transmembrane domains (TMs) spanning the lipid bilayer. Based 
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on the structure and function, the channels are categorized into three major classes: the 
voltage-gated (Kv) (six TMs), inwardly rectifying (Kir) (two TMs), and tandem pore domain 
(K2P) (four TMs) channels.38,39 
K+ channels have a similar structure that does not dependent on which class they belong. 
The common protein structure can be divided into two parts: the pore-forming domain and 
the regulatory domain. The pore-forming domain is responsible for transportation of K+ ions 
and its structure is similar in all types of K+ channels. The regulatory domain senses diverse 
stimuli and its structure differs among the classes. The basic organization of K+ channels is 
a tetramer with each monomer containing one pore-forming domain. Four pore-forming 
domains comprise a pore through which the ions are transported. K+ channels are highly 
selective and about 10 000 times more permeant for K+ than Na+ and are tightly regulated. 
K+ channels usually can be found in different opening states: resting, activated, and 
inactivated. In the resting state, the channels are closed and can be opened after activation 
stimuli, followed by turning to the nonconductive states.5,38,39 
1.3.1 Inwardly rectifying K+ channels 
Inwardly rectifying K+ channels (Kir) were firstly described as anomalous rectifier K+ 
currents. The Kir channels, under physiological conditions generate large K+ conductances 
at negative potentials close to K+ equilibrium potential and have the ability to maintain the 
resting membrane potential. The unique feature of Kir channels is that they conduct K+ ions 
on hyperpolarization, rather than on depolarization as in other K+ channels.38,40,41  
Kir channels basic molecular structure is common to all Kir, it includes two putative 
membrane-spanning domains (TM1 and TM2) linked by an extracellular pore-forming 
region and cytoplasmic amino (NH2-) and carboxyl (COOH-) terminal domains. The C-
terminal cytosolic domain is rich in β-sheets and is located below the pore-forming domain, 
extending the ion conduction pathway. The cytosolic domain also forms a binding site to 
interact with diverse intracellular regulatory mediators. Multiple ion binding sites in this 
domain are conserved and are critical to inward rectification. To form functional Kir 
channels, four subunits with two TM domains each are necessary to complete an ion 
channel in a tetrameric complex. 38,40,42,43 
Kir channels have diverse physiological functions in the cell, depending on their type and 
location and are modulated by various mediators, such as ions, phospholipids, and binding 
proteins. Several Kir subunit genes were identified and can be classified into seven 
subfamilies (Kir1.x–Kir7.x, where x is the number of each member) that belong to four 
functional groups: classical Kir channels, G protein-gated Kir channels, ATP-sensitive K+ 
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channels and K+-transport channels. Kir4.1 (encoded by KCNJ10) and Kir5.1 (encoded by 
KCNJ16) belong to the K+-transport channels and will be further discussed.38,40,44 The 
homology between the Kir channels permits homomeric and heteromeric combinations to 
form functional channels. Usually, heteromerization occurs between members of the same 
subfamily as with Kir4.1 and Kir5.1.38–40  
Kir channels are involved in maintenance of a negative resting membrane potential, 
potassium buffering, extracellular glutamate clearance, myelination, cell volume regulation 
and control of excitablility.31,41 
1.3.1.1 KCNJ10 (Kir4.1) 
KCNJ10 was first cloned from a rat brain cDNA library and as a member of the Kir family 
and requires four subunits to form a functional channel. Kir4.1 can be found as a homomeric 
or heteromeric channel complex. Kir4.1 expression was found in the brain, inner ear, retina 
(Müller cells) and kidneys. In kidneys, Kir4.1 is specifically localized in the basolateral 
membrane of renal tubules from TAL, DCT and CCD.36,39,40,45 
In the brain, Kir4.1 is involved in K+ homeostasis and maintenance of membrane potential. 
Studies with Kir4.1-/- mice revealed that in glial cells the resting membrane potential is less 
negative suggesting that Kir4.1 may be essential to K+ recycling.39 In the inner ear, Kir4.1 
channels are expressed as a homomeric channels in the stria vascularis and contributes to 
the formation and maintenance of the endocochlear potential. It has been suggested that 
mutations in KCNJ10 impair K+ secretion and alter composition and potential of the 
endolymph.46,47 
In the kidney, Kir4.1 subunits were prominently expressed along TAL, DCT and more distal 
segments.31,48 In these nephron segments, Kir4.1 is necessary for K+ recycling across the 
basolateral membrane maintaining the gradient necessary for the activity of Na+/K+-
ATPase. Kir4.1 is also involved in maintaining the electrolyte transport in the DCT, 
documented by the loss-of-function mutations in Kir4.1.16,30,41,49 
Kir4.1 channels expressed in heterologous expression systems are characterized by a high 
open probability (Po ~ 0.9) and a single channel conductance of around 20 pS and a rather 
weak sensitivity to changes of the intracellular pH around physiological values.30,50,51 Recent 
studies reported that the major contributor to the basolateral membrane conductance in 
DCT cells is an inward channel with single channel conductance between 40-45 pS. It has 
been proposed that the channel is composed by Kir4.1 and Kir5.1, a heteromeric Kir 
channel.39,52–55 
Introduction 
-14- 
 
1.3.1.2 KCNJ16 (Kir5.1) 
Kir5.1, like all other Kir family members, requires four subunits to form a functional channel. 
The channel may be either homo- or heteromeric, however homomeric Kir5.1 channel 
complexes do not produce detectable K+ currents in expression systems.56 KCNJ16 is 
localized in the brain, kidney, spleen, adrenal glands and cochlea.10,39,40 
Even though homomeric Kir5.1 does not seem to form functional channels, expression of 
Kir5.1 was observed in fibrocytes in the spiral ligament of the lateral wall of the cochlea 
(Figure 4). The distribution of Kir5.1 is distinct from that of Kir4.1 in the inner ear. Since 
homomeric Kir5.1 is likely not forming a functional channel, the localization of Kir5.1 without 
the presence of Kir4.1 is puzzling, although a role of Kir5.1 in the hearing process was 
suggested.40,46 Besides heteromerization with Kir4.1, Kir5.1 might form heteromeric channel 
complexes with its close homologue Kir4.2. Kir4.2 is encoded by KCNJ15 and its expression 
was found in kidney, brain, lungs, liver and pancreas. In pancreas, Kir4.2 is involved in the 
resting membrane potential of β-cells, preventing membrane depolarization.39 The co-
expression of Kir5.1 and Kir4.2 affects the sensitivity of Kir4.2 to intracellular pH and 
changes the rectification properties and stability of heteromeric complexes. The formation 
of Kir4.2-Kir5.1 heteromers may form in tissues where Kir4.1 is not expressed, for example 
in the pancreas.39,57,58 
 
 
Figure 4. Kir5.1 promotor-driven X-Gal staining of mouse cochlea. 
Blue staining indicates promotor-driven X-gal staining in transgenic Kir5.1-/- mice carrying the LacZ 
gene within the gene locus. The spiral shaped blue color of positive cells was observed in the turns 
of Kir5.1-/- cochlea (white arrows on the left). Positive staining on a cochlea section was visible in the 
organ of Corti and hair cells (black arrows on the right). Abbreviation: HC, hair cells; X-Gal, 5-bromo-
4-chloro-3-indolyl-β-D-galactopyranoside; LacZ, lactose operon. 
Expression of Kir5.1 in the kidney is mainly found in the distal nephron segments that 
consists of TAL, DCT and CNT/CCD where it co-localizes with Kir4.1. Due to the nature of 
Kir5.1, it most likely associates with Kir4.1. Heteromeric Kir4.1-Kir5.1 have been shown to 
have pH sensitivity in the physiological intracellular range (pKa ~ 7.45). Kir5.1 seems to 
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confer an enhanced sensibility to intracellular pH to Kir4.1-Kir5.1 channels.36,39,55,59 The pH 
sensitivity of Kir4.1-Kir5.1 heteromeric channels in the physiological pH range has led to the 
assumption that Kir4.1-Kir5.1 might be a good candidate for CO2 chemoreception. The pKa 
of 7.4 might allow those channels to regulate membrane potentials in response to modest 
changes in pCO2. Cui et al. discovered that in the oocyte expression system heteromeric 
Kir4.1-Kir5.1 channels were modulated by changes in pCO2 leading to changes of the 
membrane voltage. Therefore, the cells could detect states of hyper- and hypocapnia and 
translate it into a modified membrane excitabiliy. However, the precise contribution of 
Kir4.1-Kir5.1 to chemosensation is still a matter of debate, since the loss of Kir5.1 appeared 
to be compensated thereby leaving the ventilatory responses intact.60–62 
In Kir5.1-/- mice, it was observed that in the absence of Kir5.1 the remaining K+ channel 
present in DCT had a conductance of ~25pS instead of ~50pS observed in control animals. 
This smaller single channel conductance is typical for homomeric Kir4.1 channels indicating 
that the physiological K+ channels in mouse DCTs are heteromeric Kir4.1-Kir5.1 channel 
complexes. Co-expression of Kir4.1 and Kir5.1 subunits lead to the formation of a 40-60 pS 
single channel K+ conductance and a lower open probability (Po ~ 0.4) when compared with 
homomeric Kir4.1. 50,51,54 The expression of heteromers in the basolateral membrane of the 
distal tubule was suggested to be involved in the recycling of the K+ across the basolateral 
membrane, necessary for maintenance of the activity of Na+/K+-ATPase.31,50,51,53,59 Deletion 
of KCNJ16 in mice led to a renal phenotype characterized by hypokalemia, hyperchloremic 
metabolic acidosis with hypercalciuria.54 The authors concluded that disruption of KCNJ16 
induces a severe renal phenotype that, apart from hypokalemia, is the opposite of the 
phenotype seen in EAST/SeSAME syndrome. This phenotype was attributed to increased 
mean basolateral K+ conductance mediated by the remaining homomeric Kir4.1 channels 
in the distal nephron.54,60,61,63 
For KCNJ16, unlike KCNJ10, no mutations have yet been associated with human 
pathologies. However, our collaborator Prof. Dr. Konrad Martin in Münster identified a 
patient, who suffers from renal salt wasting, hypokalemia and acidosis and has the 
c.104G>A mutation (NCBI Reference Sequence: NM_001291625.1) within the KCNJ16 
gene (unpublished data). This mutation leads to the missense mutation p.Arg35Gln (R35Q) 
in KCNJ16 (UniProt: Q9NPI9), replacing the charged aliphatic arginine (R) to the neutral 
and polar amino acid glutamine (Q) (Figure 5). This mutation is located at the N-terminal 
region of the protein.  
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Figure 5. Schematic topology of human Kir5.1 (UniProt Q9NPI9). 
Kir5.1 is an inwardly rectifying K+ channel containing two transmembrane regions and a pore-forming 
region in between the two regions. The missense mutation p.Arg35Gln (R35Q) found in one patient 
with hypokalemic acidosis is located in the N-terminal region of the protein. 
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2. Objectives 
Kir5.1 (KCNJ16) potassium channels are strongly expressed in the kidney. Previous work 
by Paulais and co-workers suggested that Kir5.1 together with Kir4.1 forms a basolateral 
K+ conductance in distal convoluted tubules (DCT).54 Moreover, these authors provided 
evidence that genetic inactivation of Kir5.1 leads to disturbed renal salt handling and 
hypokalemia. Surprisingly and in contrast to the alkalosis observed after inactivation of 
Kir4.1, knockout mice for Kir5.1 displayed metabolic acidosis. So far, no human disease 
has been linked to mutations of Kir5.1. Our collaborator Prof. Konrad, Münster, identified in 
a patient with hypokalemia and acidosis a homozygous missense mutation of Kir5.1 (R35Q) 
and he asked our group in Regensburg to test if this Kir5.1 mutant can be disease-causing 
or if it is only a rare variant.   
Therefore, my thesis aimed at testing the hypothesis if i) the mutation R35Q leads to 
impaired channel function and ii) inactivation of Kir5.1 disturbs salt transport in the kidney, 
especially in the DCT, thereby creating a renal tubulopathy similar to the one observed in 
Prof. Konrad's patient.  
To investigate the functional consequence of the R35Q mutant, I co-expressed Kir5.1 and 
Kir4.1 in a heterologous expression system and studied the subcellular localization of Kir5.1 
and the electrophysiological properties in those transfected cells. 
In the second part of my thesis, I studied the consequences of the Kir5.1 gene inactivation 
in mice in vivo with the focus on renal salt handling, pH homeostasis, K+ induced Ca2+ 
signaling in DCT cells and respiratory control.  
With these sets of experiments, I hoped to gain insights into the pathophysiology of a 
potentially novel human disease and to establish - or falsify - a genotype/phenotype 
correlation. 
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3. Materials and Methods 
3.1 Material 
3.1.1 Instruments 
Instruments Manufacturer 
Blood Gas Analyzer pHOx plusM Nova Biomedical, Rödermark, Germany 
Cryostar NX70 Thermo Fisher Scientific, Dreieich, Germany 
Cryostat Leica CM3050 Leica, Wetzlar, Germany 
EPC 10 Amplifier Patch-Clamp 
HEKA Elektronik Dr. Schulze GmbH, Pfalz, 
Germany 
Gas mixer for Isoflurane-Vaporizer 
MFI Föhr Medical Instruments GmbH, 
Seeheim, Germany 
Incubator Heraeus Instruments, Osteode, Germany 
Inverted Microscope Axiovert 10 Zeiss, Jena, Germany 
Inverted Microscope Axiovert 200 Zeiss, Jena, Germany 
Inverted Microscope Observer Z.1 Zeiss, Jena, Germany 
Ion Chromatography ICS-1600 Dionex Thermo Fisher Scientific, Dreieich, Germany 
Isoflurane-Vaporizer 
MFI Föhr Medical Instruments GmbH, 
Seeheim, Germany 
Laminar Flow Thermo Fisher Scientific, Dreieich, Germany 
Light-Cycler LC480 Roche, Mannheim, Germany 
Microcentrifuge Hettich, Tuttlingen, Germany 
Microtome (Rotary microtome RM2165) Leica, Wetzlar, Germany 
Millicell® ERS-2 Voltohmmeter Merck, Darmstadt, Germany 
Mini Trans-Blot Cell Bio-Rad, Munich, Germany 
Mini-PROTEAN Tetra Vertical 
Electrophoresis Cell 
Bio-Rad, Munich, Germany 
NanoDrop 2000c Spectrophotometer Thermo Fisher Scientific, Dreieich, Germany 
NOVOstar Microplate reader BMG Labtech, Ortenberg, Germany 
NOVOstar Microplate reader BMG Labtech, Ortenberg, Germany 
O2 sensor Oxydig 
Dräger, Ultra Medical GmbH, 
Saarbruecken-Gersweiler, Germany 
Paraffin incubator 
Modell 300, Memmert, Schwabach, 
Germany 
PatchStar Micromanipulator Scientifica, United Kingdom 
Perfusor 
Precidor 902681, Infors AG, Bottmingen, 
Switzerland 
Peristaltic perfusion system PP52 
Multichannel systems MCS GmbH, 
Reutlingen, Germany 
pH electrode Schott Geräte, Mainz, Germany 
Plethysmography chamber EMKA Technologies Company, USA 
PowerLab 4/30 ADInstruments Ltd., United Kingdom 
PowerPac Basic Power Supply Bio-Rad, Munich, Germany 
Roller pump Ismatec SA., Zurich, Switzerland 
Scale (EK-600) A&D Instruments Ltd, Tokio, Japan 
Sound-attenuated chamber 
Industrial Acoustics, Niederkrüchten, 
Germany 
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Surgery instruments FST, Bad Oeynhausen, Germany 
Thermomixer 5436 Eppendorf GmbH, Hamburg, Germany 
Warm plate for mouse operations Dr. J. Barhanin, Nizza, France 
Warm plate for paraffin HI 1220, Leica, Wetzlar, Germany 
Water bath Modell W13, Haake, Karlsruhe, Germany 
 
3.1.2 Laboratory Material 
Products Manufacturer 
0.5 ml Insulin-syringe 
BD Micro-Fine+, BD Consumer Healthcare, 
Heidelberg, Germany 
 
96-well plate 
Nuclon Surface, Nunc A/S, Roskilde, 
Denmark 
96-well Polymerase chain reaction (PCR) 
Plate, white 
Nerbe Plus GmbH, Winsen/Luhe, Germany 
Blood gas capillary 
Hirschmann Labor geräte GmbH & Co. KG, 
Eberstadt, Germany 
Cell culture flasks (T-25, T-75) 
Nuclon Surface, Nunc A/S, Roskilde, 
Denmark 
Cell Culture Inserts, 0,4µm PCF, 12mm 
diameter 
Merck Millipore, Darmstadt, Germany 
Cell culture plates (6-well, 12-well, 24-
well) 
Nuclon Surface, Nunc A/S, Roskilde, 
Denmark 
Cell scraper 
TPP Techno Plastic Products AG, 
Trasadingen, Switzerland 
Coverslips  A. Hartenstein GmbH, Würzburg, Germany 
DePeX mounting medium 
Serva Electrophoresis GmbH, Heidelberg, 
Germany  
Epoxy embedding medium Sigma, Taufkirchen, Germany 
Eppendorf microplestle for 1,2 – 2 mL 
tubes 
A. Hartenstein GmbH, Würzburg, Germany 
Eppendorf Tubes (0,2 ml, 0,5 ml, 1,5 ml, 2 
ml) 
Eppendorf AG, Hamburg, Germany 
Falcon tubes (15 ml, 50 ml) Greiner bio-one, Frickenhausen, Germany 
Filter paper 
GE Healthcare Life Sciences, 
Buckinhamshire, UK 
GeneRuler™ DNA Ladder (50 bp, 100 
bp, 1 kb) 
MBI Fermentas GmbH, St. Leon-Rot, 
Germany 
Latex gloves Kimberly-Clark, Roswell, USA 
Light-Cycler Capillaries Roche, Mannheim, Germany 
Millex-GP Syringe Filter Unit, 0.22 µm, 
polyethersulfone, 33 mm, gamma 
sterilized 
Merck Millipore, Darmstadt, Germany 
Millicell® Cell Culture Inserts, 0,4 µm Merck, Darmstadt, Germany 
Mortar Rosenthal Technik, Tostedt, Germany 
Nanosep Centrifugal VWR International, Darmstadt, Germany 
Non-fluorescent Glycergel mounting 
medium 
DakoCytomation, Dakato North America 
Inc., Carpinteria, USA 
Pasteur pipettes Brand, Wertheim, Germany 
Pestle Rosenthal Technik, Tostedt, Germany 
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Petri dishes (p35, p60, p100 mm) 
Nuclon Surface, Nunc A/S, Roskilde, 
Denmark 
Pipette tips (10 µl, 200 µl, 1000 µl) Sarstedt, Nümbrecht, Germany 
Polysine microscope adhesion slides Kindler, Freiburg, Germany 
Polyvinylidene difluoride (PVDF) 
membrane 
GE Healthcare GmbH, Freiburg, Germany 
Serological Pipettes Nerbe Plus GmbH, Winsen/Luhe, Germany 
Tissue cassettes for paraffin blocks A. Hartenstein GmbH, Würzburg, Germany 
Tissue Tek OCT-Medium 
Sakura Finetek Europe B.V., Zoeterwoude, 
Netherlands 
 
3.1.3 Substances 
Products Manufacturer 
0.9% NaCl isotonic solution 
B. Braun Melsungen AG, Melsungen, 
Germany 
2-Methylbutane 
Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
2x Laemmli Sample Buffer Bio-Rad, Munich, Germany 
4x Laemmli Sample Buffer Bio-Rad, Munich, Germany 
Acetic acid (glacial) Merck, Darmstadt, Germany 
Agarose AppliChem, Darmstadt, Germany 
Ammonium acetate Sigma, Taufkirchen, Germany 
Ammonium persulfate Sigma, Taufkirchen, Germany 
ATP-Na2 (Adenosine 5′-triphosphate 
disodium salt) Sigma, Taufkirchen, Germany 
BaCl2 Sigma, Taufkirchen, Germany 
Bradford Protein Assay Bio-Rad, Munich, Germany 
BSA (Albumin from bovine serum) Sigma, Taufkirchen, Germany 
CaCl2 
Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
Ca-Gluconate monohydrate Carl Roth GmbH + Co. KG, Karlsruhe, D 
Chloroform Sigma, Taufkirchen, Germany 
Citric acid monohydrate Sigma, Taufkirchen, Germany 
Creatinine Sigma, Taufkirchen, Germany 
D-Mannitol Fluka Chemie GmbH, Buchs, CH 
D-Potassium gluconate Sigma, Taufkirchen, Germany 
EDTA Sigma, Taufkirchen, Germany 
EGTA Sigma, Taufkirchen, Germany 
Eosin Y Abcam, Cambridge, UK 
Ethanol J. T. Baker, Deventer, Netherlands 
FCS (Fetal Calf Serum) 
Gibco Cell Culture Systems - Invitrogen, 
Karlsruhe, Germany 
Fura-2 AM 
Invitrogen, ThermoFisher, Darmstadt, 
Germany 
Glucose Merck, Darmstadt, Germany 
Glutaraldehyde solution Sigma, Taufkirchen, Germany 
Glycerol Sigma, Taufkirchen, Germany 
Glycine Merck, Darmstadt, Germany 
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HCl Merck, Darmstadt, Germany 
Heparin 
Liquemin N 25000, 5 ml, Roche, Mannheim, 
Germany 
HEPES AppliChem, Darmstadt, Germany 
IGEPAL CA-630 Sigma, Taufkirchen, Germany 
Isoflurane 
Baxter Deutschland GmbH, 
Unterschleißheim, Germany 
Isopropanol Merck, Darmstadt, Germany 
K2HPO4 Merck, Darmstadt, Germany 
K3[Fe(CN)6] Merck, Darmstadt, Germany 
K4[Fe(CN)6] Sigma, Taufkirchen, Germany 
KCl Merck, Darmstadt, Germany 
Ketamine 100mg/mL Sigma, Taufkirchen, Germany 
KH2PO4 •3H2O Merck, Darmstadt, Germany 
L-Glutamine, 200 mM (100x) 
Gibco Cell Culture Systems - Invitrogen, 
Karlsruhe, Germany 
Mayer’s hemalun solution 
Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
MEM alpha medium 
Gibco Cell Culture Systems - Invitrogen, 
Karlsruhe, Germany 
Methanol Merck, Darmstadt, Germany 
MgCl2 •6H2O Merck, Darmstadt, Germany 
MgSO4 •7H2O Merck, Darmstadt, Germany 
Na2HPO4 •2H2O Merck, Darmstadt, Germany 
NaCl Merck, Darmstadt, Germany 
NaH2PO4 Merck, Darmstadt, Germany 
NaH2PO4 •H2O Merck, Darmstadt, Germany 
Nonfat-dried milk AppliChem GmbH, Darmstadt, Germany 
Opti-MEM 
Gibco Cell Culture Systems - Invitrogen, 
Karlsruhe, Germany 
Opti-MEM™, Reduced Serum Medium Thermo Fisher Scientific, Dreieich, Germany 
Paraffin 
Paraplast-Plus Paraffin, Sherwood, St. 
Louis, USA 
Paraformaldehyde Merck, Darmstadt, Germany 
Penicillin-Streptomycin solution 
1000 I.E./ml Pen G, 10000 µg/ml Strep.-
Sulfat, Gibco Cell Culture Systems - 
Invitrogen, Karlsruhe, Germany 
Periodic acid Thermo Fisher Scientific, Dreieich, Germany 
Picric acid Sigma, Taufkirchen, Germany 
Polyethylene glycol Sorbitan Monolaurate 
(Tween 20) 
Sigma, Taufkirchen, Germany 
Precision Plus Protein™ Dual Color 
Standards 
Bio-Rad, Munich, Germany 
Protease Inhibitor Cocktail Set III, EDTA-
Free 
Merck, Darmstadt, Germany 
Rotiphorese® Gel 30 (37,5:1) 
(30% Acrylamide) 
Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
Schiff’s reagent Sigma, Taufkirchen, Germany 
SDS (dodecyl sulfate) Merck, Darmstadt, Germany 
Sodium acetate Merck, Darmstadt, Germany 
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Sodium azide Sigma, Taufkirchen, Germany 
Sodium citrate dehydrate Merck, Darmstadt, Germany 
Sodium deoxycholate Sigma, Taufkirchen, Germany 
Sodium Pyruvate, 100 mM solution Sigma, Taufkirchen, Germany 
Sucrose Merck, Darmstadt, Germany 
TEMED 99%, for electrophoresis 
Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Tris Hydrochloride Merck, Darmstadt, Germany 
Triton X-100 Sigma, Taufkirchen, Germany 
TRIzol™ Reagent Thermo Fisher Scientific, Dreieich, Germany 
Trypsin-EDTA (10x) solution 
0,5% Trypsin, 5,3 mM EDTA, Gibco Cell 
Culture Systems - Invitrogen, Karlsruhe, 
Germany 
Western Blotting Luminol Reagent Santa Cruz, Heidelberg, Germany 
X-Gal (5-Bromo-4-chloro-3-indolyl-β-D-
galacto-pyranoside) 
Sigma, Taufkirchen, Germany 
Xylol Merck, Darmstadt, Germany 
α-Ketoglutarate (α-Ketoglutaric acid) Sigma, Taufkirchen, D 
β-Mercaptoethanol Merck, Darmstadt, Germany 
 
3.1.4 Enzyme, Kits 
Products Manufacturer 
Collagenase Typ II (from Clostridium 
histolyticum) 
Sigma, Taufkirchen, D 
DNAse I 
Roche Diagnostics GmbH, Mannheim, 
Germany 
dNTP-Mix 
MBI Fermentas GmbH, St. Leon-Rot, 
Germany 
M-MLV Reverse Transkriptase Promega, Madison, Wisconsin, USA 
M-MLV Reverse Transkriptase Puffer (5x) Promega, Madison, Wisconsin, USA 
Protease (from Streptomyces griseus) Sigma, Taufkirchen, D 
Random Hexamer Primer (100 µM) 
MBI Fermentas GmbH, St. Leon-Rot, 
Germany 
REDTaq® ReadyMix™ PCR Reaction Mix Sigma, Taufkirchen, Germany 
RNAse Inhibitor 
Peqlab Biotechnologie GMBH, Erlangen, 
Germany 
RNeasy mini kit Quiagen, Hilden, Germany 
SYBR® Green PCR Kit   Quiagen, Hilden, Germany 
Quick Ligase New England Biolabs, Frankfurt, Germany 
Trypsin inhibitor 
Roche Diagnostics GmbH, Mannheim, 
Germany 
Lipofectamine Thermo Fisher Scientific, Dreieich, Germany 
Gel extraction Kit QIAGEN GmbH, Hilden, Germany 
NucleoSpin Plasmid 
Macherey-Nagel GmbH & Co. KG, Düren, 
Germany 
NucleoBond Xtra MIDI 
Macherey-Nagel GmbH & Co. KG, Düren, 
Germany 
RNeasy Mini Kit QIAGEN GmbH, Hilden, Germany 
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3.1.5 Software 
Product Manufacturer 
ImageJ V1.37c Wayne Rasband, NIH, USA 
Labchart® Reader V7.1 
ADInstruments, Ltd, Oxford, United 
Kingdom 
IOX v1.8 EMKA Technologies EMKA Technologies Company, USA 
Origin 2017 OriginLab Corporation, Northampton, USA 
ZEN Pro V2.3 Zeiss, Jena, Germany 
Patch Master V2x65 
HEKA Elektronik Dr. Schulze GmbH, Pfalz, 
Germany 
Corel draw X8 Corel corporation, Ottawa, Canada 
 
3.1.6 Oligonucleotide 
All oligonucleotides were prepared by Invitrogen, Karlsruhe, Germany. 
All primers were prepared for Mus musculus, unless otherwise mentioned. 
 
Genotyping of KCNJ16 mice 
m = mouse 
Gene Primer Sequence Annealing-T. 
Kcnj10 (Kir4.1) 
sense AGTCTTGGCCCTGCCTGT 
55 ˚C 
antisense TTAGCGACCGACGTCATCT 
Kcnj16 (kir5.1) 
sense TACCGCTGTGTCACCGAAGA 
62 ˚C 
antisense GCCAAGGCTGCTCCAATGAT 
Kcnj15 (Kir4.2) 
sense CCCACTGGTGAAGCATACCAA 
62 ˚C 
antisense CGATGACGGTTGTCCACAAGT 
Lrp2 (Megalin) 
sense CAGTCAGTGGCCAAGAATG 
57 ˚C 
antisense CAGTCTCTGGTCCCATCAC 
Nphs2 (Podocin) 
sense CCATCTGGTTCTGCATAAAGG 
57 ˚C 
antisense CCAGGACCTTTGGCTCTTC 
Calb1 (Calbindin-
D28K) 
sense CACAGACCTCATGCTGAAAC 
57 ˚C 
antisense GGTAGTAACCTGGCCATCTC 
Slc12a3 (NCC) 
sense GCTGACCTGCATTCATTCCT 
57 ˚C 
antisense GACCTTGCCGTCCATCAAAG 
Slc12a1 (NKCC2) 
sense TCTGCATCTGCTGCGAAG 
61 ˚C 
antisense GGACACCGTCCCTGAAGC 
MCOLN 
(Mucolipin) 
sense AGATGAGGCGGAAACTCAAGT 
61 ˚C 
antisense CCATTCGATCCATGTAGCCCT 
Actb (β-Actin) 
sense CCACCGATCCACACAGAGTACTT 
57 ˚C 
antisense GACAGGATGCAGAAGGAGATTACTG 
mKcnj16 wildtype 
sense CCTCCAGAGCATGCCATCGC 
63 ˚C 
antisense GATCGCTTAATAGGTCTCCG 
mKcnj16 knockout 
sense GCAGCGCATCGCCTTCTATC 
60 ˚C 
antisense TACAAACTCTACTGCCAAAGC 
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Site directed mutagenesis of KCNJ6 R35Q 
h = human 
 
3.1.7 Antibody 
Target Type Dilution Manufacturer 
anti-Kir4.1, rabbit polyclonal IgG Prim. Ab 1:400 Alomone Labs 
anti-Kir5.1, rabbit polyclonal IgG Prim. Ab 1:400 Sigma Prestige Antibody 
anti-AQP2, goat polyclonal IgG Prim. Ab 1:400 Santa Cruz Biotechnologies 
Anti-calbindin, mouse monoclonal 
IgG 
Prim. Ab 1:400 Sigma Life Science 
Anti-NKCC2, rabbit Prim. Ab 1:400 Mark Knepper 
Anti-cubilin (T-16), goat polyclonal 
IgG 
Prim. Ab 1:200 Santa Cruz Biotechnology 
    
Alexa Fluor® 488 donkey anti-
mouse 
Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
Alexa Fluor® 488 donkey anti-
rabbit 
Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
Alexa Fluor® 546 donkey anti-goat Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
Alexa Fluor® 647 donkey anti-
rabbit 
Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
Cy5 donkey anti-mouse Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
HOE33342 (Stock conc.: 5x10-4 M) Sec. Ab 1:400 Invitrogen, Karlsruhe, D. 
 
3.1.8 Buffers and solutions 
Designation Substance Quantity 
Fixation solution, pH 7.4 
EGTA 1 mM 
K2HPO4 15 mM 
MgCl2 2 mM 
NaCl 90 mM 
Paraformaldehyde 3% 
Sucrose 100 mM 
Aqua dest. 
   
Phosphate buffered saline (PBS), pH 7.4 
KH2PO4 1.8 mM 
Na2HPO4 10.3 mM 
NaCl 137 mM 
in Aqua dest. 
 
hKcnj16 R35Q 
sense AAGAGCAAGAAGACAATTACTTCAC 
55 ˚C 
antisense GTGAAGTAATTGTCTTCTTGCTCTT 
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Post fixation solution, pH 7.4 
EGTA 1 mM 
K2HPO4 15 mM 
MgCl2 2 mM 
NaCl 90 mM 
Paraformaldehyde 1% 
Sucrose 17% 
in Aqua dest. 
 
PBS-Tween 
PBS 99,9% 
Tween 20 0,1% 
 
2% Glutaraldehyde Solution, pH 7,4 
Glutaraldehyde 2% 
Sodium cacodylate 0,1 M 
in distilled water 
 
Citrate buffer, pH 6.0 
Sodium citrate dehydrate 2.059 g 
Citric acid monohydrate 0.317 g 
in Aqua dest. ad 1000 ml 
 
0,1% SDS Solution 
SDS 0,1% (v/v) 
in PBS 
   
Blocking solution, pH 7.4 
BSA 5% 
Triton X-100 0.04% 
in PBS buffer 
   
 
  
Solution for Antibody dilution, pH 7.4 
BSA 0.5% 
Triton X-100 0.04% 
in PBS buffer 
 
1% Periodic acid solution Periodic acid 1% (w/v) 
in distilled water 
 
X-Gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside) solution I, pH 7.4 
Sodium deoxycholate 1 mg/mL 
IGEPAL CA-630 2 mg/mL 
EGTA 5 mM 
MgCl2 2 mM 
K2HPO4 100mM 
in distilled water 
 
X-Gal solution II 
X-Gal 0.5 mg/mL 
K3[Fe(CN)6] 10 mM 
K4[Fe(CN)6] 10 mM 
in X-Gal solution I 
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Sorting solution, pH 7.4  
Bovine serum albumin (BSA) 500 mg/L 
In digestion sol. 
 
Digestion solution I, pH 7.4 
NaCl 140 mM 
KH2PO4  0.4 mM 
K2HPO4 •3 H2O 1.6 mg/ml 
MgSO4 •7 H2O 1 mM 
Na-Acetat •3 H2O 10 mM 
α-ketoglutaric acid 1 mM 
Calcium gluconate 
monohydrate 
1.3 mM 
in Aqua dest. 
 
Incubation solution, pH 7.4 Glycine 375 mg/L 
 Trypsin inhibitor 48 mg/L 
 DNAse I 25 mg/L 
 in digestion sol.  
   
Digestion solution II, pH 7.4 
Collagenase II 2 mg/mL 
In incubation solution 
   
Control solution, pH 7.4 
(Fura-2-AM Ca2+ Measurements) 
HEPES 5 mM 
NaCl 130 mM 
Na2HPO4 •2H2O 1.6 mM 
NaH2PO4 •H2O 0.4 mM 
Glucose 5 mM 
MgCl2 1 mM 
CaCl2 1.3 mM 
in Aqua dest. 
   
Fura-2-AM solution, pH 7.4 
Fura-2-AM 5 µM 
BSA 0.1 mg 
in control solution 
   
 
HEK cells medium 
Fetal Calf Serum (FCS) 
(heat-inactivated) 
10% 
 Penicillin-Streptomycin 
solution 
1% 
 MEM ALPHA medium 500 mL 
 
CHO cells medium 
FCS (heat-inactivated) 10% 
Penicillin-Streptomycin 
solution 
1% 
L-Glutamine 2 mM 
Sodium Pyruvate 1 mM 
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MEM ALPHA medium 500 mL 
 
Patch clamp Solution pH 7.4 
CaCl2 1.3 mM 
Glucose 5 mM 
HEPES 5 mM 
K2HPO4 •3H2O 1.6 mM 
KH2PO4 0.4 mM 
MgCl2 1 mM 
NaCl 145 mM 
in Aqua dest. 
 
Barium solution, pH 7.4 BaCl 5 mM 
(Patch-Clamp Measurements) in control solution 
 
Pipette solution, pH 7.2 
(Patch-Clamp Measurements) 
Potassium Gluconate 95 mM 
KCl 30 mM 
Na2HPO4 •2H2O 4.8 mM 
NaH2PO4 •H2O 1.2 mM 
Glucose 5 mM 
MgCl2 2.38 mM 
CaCl2 0.726 mM 
EGTA 1 mM 
ATP-Na2 3 mM 
in Aqua dest. 
3.2 Methods 
3.2.1 Mice 
3.2.1.1 KCNJ16 knockout model 
To investigate the importance of Kir5.1 (encoded by the Kcnj16 gene), a knockout mouse 
(Kir5.1-/-) was used as a model organism. The Kir5.1-/- mouse model was generated by 
Taconic (TF0347) with a genetic background of 129/SvEv-C57BL/6. Mice were 
backcrossed for at least 5 generations into the C57BL/6J background before experiments 
were performed. As control animals (Kir5.1+/+), mice from the same strain (C57BL6J) were 
used. All animals were kept according to the current German animal welfare law. The mice 
had a 12 hour light and dark rhythm and were kept on a standard diet (Sniff V1124) with 
free access to water. For the experiments, we took animals of both sexes (unless otherwise 
stated). 
3.2.1.2 Isolation of genomic DNA 
Tail biopsies (2 mm) of mice were taken to isolate genomic DNA (gDNA). Tails were 
digested over night at 55 ˚C, in 300 µL Tail Buffer (0.1 M EDTA, 0.5% SDS, 50 mM Tris-
Materials and Methods 
-28- 
 
HCl, pH 8) with 1 µL Proteinase K (100 mg/mL). The next day, 100 µL of ammonium acetate 
(7.5 M) were added to the digested tails, followed by 600 µL of isopropanol, always with 
proper homogenization of the solution. For the DNA to precipitate, the mixture was 
incubated for 20 minutes at -20 ˚ 
Probes were centrifuged for 10 minutes at 13000 rpm in order to obtain the DNA pellet. The 
pellet was washed with 1 mL of 70% Ethanol, centrifuged once again and supernatant was 
discarded. Finally, after air drying of the sample for 15 minutes, gDNA was resuspended in 
80 µL of TE buffer (10 mM Tris, 1 mM EDTA, pH 7.5) and stored at 4 ˚C. 
3.2.1.3 Genotyping of KCNJ16 knockout mice 
Genotyping was performed by PCR using the Red Taq Mix. The PCR master mix was 
prepared using 1 µL of mouse gDNA, 10 µL Red Taq Mix 2x, 7 µL H2O and 1 µL of sense 
and antisense primers corresponding to the wildtype and knockout alleles (Section 3.1.6). 
The conditions used for the run are described in Table 1. 
Table 1. PCR program for KCNJ16 genotype. 
Temperature Time Repetitions 
94 °C 4 min  
94 °C 15 sec 
10 cycles 65 °C 30 sec 
72 °C 30 sec 
94 °C 15 sec 
30 cycles 55 °C 30 sec 
72 °C 30 sec 
72 °C 2 min  
10 °C ∞  
The amplified products of wildtype (wt) and KCNJ16 knockout (ko) alleles were separated 
in a 2% agarose gel according to the amplicon sizes of 256 bp and 316 bp for wt and ko, 
respectively. 
3.2.1.4 Diet 4% NaCl 
Experiments were performed with Kir5.1-/- (n = 10) and control mice (n = 8, 3-4 months old) 
which were fed a standard salt diet (fortified food with 0.24% sodium, V1124; Ssniff 
Spezialdiäten GmbH) and water ad libitum. Before the experimental diet, animals were 
weighted; urine samples (spot urine) and blood from the facial vein were collected for basal 
conditions. Animals were allowed to recover for 7 days. Thereafter, food was switched to 
high sodium content 4% NaCl (E15431-34; Ssniff Spezialdiäten GmbH) with free access to 
water. During the time of the diet, the body weight was monitored daily, for 15 consecutive 
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days and urine samples were collected every two days. At the end of experiment, blood 
samples were collected from the facial vein and blood electrolytes were analyzed using the 
blood gas system pHOx plus M. 
3.2.1.4.1 Amiloride 
Experiments were performed with Kir5.1-/- (n = 9) and control mice (n = 12, 3-5 months old) 
which were fed a standard diet (fortified food with 0.24% sodium, V1124; Ssniff 
Spezialdiäten GmbH) and water supplemented with 6% sucrose, 25 mM NaCl and 50 mM 
KCl, 24 h before experiment. The animals were weighted and the bladder emptied before 
placed in the metabolic cages. No food was allowed during the experiment time, and urine 
was collected during 6h. Afterwards, an intraperitoneal injection of amiloride (5 μg/body 
weight (BW)) was given and the urine collected for 6h. Urine samples were analyzed by ion 
chromatography according to manufacturer’s instructions. 
3.2.1.4.2 Collection of blood and urine samples 
Blood samples were obtained from the facial vein of the KCNJ16-/- and control mice. Blood 
samples were collected into 150 μL glass capillaries and analyzed immediately using the 
blood gas system pHOx plus M (Nova Biomedical). In addition to blood gases (pO2 and 
pCO2), the device measured electrolytes, such as, Na+, K+, Ca2+, Mg2+ and also the pH of 
the sample. Additionally, several blood parameters were calculated by the device according 
to pHOx Plus M Analyzer manual, using the following equations: 
 
Bicarbonate [𝐻𝐶𝑂3
−]: 
𝑝𝐻 = 𝑝𝐾 + 𝑙𝑜𝑔
[𝐻𝐶𝑂3
−]
𝛼(𝑝𝐶𝑂2)
 
 
Rearranging of Henderson-Hasselbalch equation, where pH and pCO2 are measured and 
pK = 6.091 and α = 0.03707 (solubility coefficient of CO2 in plasma at 37 °C), gives equation: 
 
𝑙𝑜𝑔10[𝐻𝐶𝑂3
−] = 𝑝𝐻 + 𝑙𝑜𝑔10𝑝𝐶𝑂2 − 7.604 
 
Base excess (BE) of the blood is defined as the concentration of titratable base needed to 
titrate blood to pH 7.40 at 37 °C while the pCO2 is held constant at 40 mm Hg and is 
calculated as: 
 
BE = (1 − 0.014[Hb])([HC𝑂3
−] − 24 + (1.43[𝐻𝑏] + 7.7)(𝑝𝐻 − 7.4), 
 
Materials and Methods 
-30- 
 
Hb-hemoglobin 
 
Urine samples were collected before and during the diet period. The adult mice emptied 
their bladder spontaneously after being removed from their cage and urine samples were 
collected into an Eppendorf and analyzed by Ion Chromatography (IC) Dionex ICS-1600 
(Thermo Scientific) for identification and quantification of numerous ions. The samples were 
prepared and measured by Ines Tegtmeier according to the manufacturer´s instructions. 
3.2.2 Cell line 
As cell models, two different cell lines were chosen: human embryonic kidney (HEK; single 
channel experiments) and Chinese hamster ovary (CHO; whole cell experiments) cells. The 
cells were cultivated at 37 °C, 5% CO2 in media described in section 3.1.9. For transfection 
500.000 cells were seeded into 6-wells on glass cover slips one day prior to transfection 
with 0.5 μg of cDNA (unless otherwise stated) using the Lipofectamine according to the 
manufacturer’s protocol. For cotransfection experiments, the cells were transfected with 
wildtype KCNJ10 and wildtype or mutant KCNJ16 (KCNJ16wt or KCNJ16R35Q) in pIRES CD8 
plasmids. Different stoichiometric ratios were used: a ratio of 1:1 to understand the role of 
KCNJ16 channels in the overall conductance and a ratio of 1:10 (one part KCNJ10 and nine 
parts KCNJ16) to avoid contamination with homomeric KCNJ10 channels. Cells were 
analyzed two days after transfection by immunofluorescence or electrophysiology 
experiments. 
Cells were transfected with bicistronic pIRES CD8 plasmids, which included the 
transmembrane protein CD8 in addition to the desired protein target KCNJ10, KCNJ16 or 
mutant KCNJ16R35Q. This allowed the use of Dynabeads™ CD8, which are beads coated 
with a specific monoclonal antibody against human CD8 allowing visual identification of 
cells that expressed the target proteins. 
3.2.3 Histological Methods 
3.2.3.1 Tissue fixation by retrograde arterial perfusion 
Mice were anesthetized with isoflurane (through inhalation of a gas mixture composed of 
2.5% of isoflurane, 50% oxygen and 50% nitrogen at 60 mL/min flow). In deep anesthesia 
the abdominal cavity was opened and the abdominal aorta was freed from overlaying 
adipose and connecting tissues and temporarily clamped shortly distal of the renal artery. 
Then, a small incision was made into the the distal abdominal aorta in order to insert a 
polyethylene catheter. The catheter was fixed with a second clamp. After incision of the 
inferior vena cava and removal of the first clamp, the animals were killed by replacing the 
blood with 0.9% NaCl supplemented with 10 IU/mL of Heparin. After 10 mL of perfusion, 
Materials and Methods 
-31- 
 
the dead mice were perfused with a fixation solution, at a constant flow rate of 10 mL/min 
assured by a roller pump. 
3.2.3.2 Cryo preparation and sectioning 
After perfusion of mice, the tissues were left in a post-fixation solution containing 1.5% 
paraformaldehyde and high concentration of sucrose, for 1h, at 4 ˚C. The tissues were 
frozen in 2-methylbutane, at -40 °C and then preserved at -80 ˚C. In a cryostat, sections 
were made at chamber temperature of -25 ˚C and the object holder was at -20 ˚C. After 
being applied in polysine™ microscope adhesion slides, the sections were dried for 20 min 
at room temperature and stored at -20 ˚C. 
3.2.3.3 X-Gal stain: detection of β-galactosidase activity 
The cryo-sections obtained were incubated with X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside) solution II (see recipe in 3.1.8) at 37C. Afterwards, the sections were 
immersed in PBS and mounted with Dako mounting medium. 
X-gal staining is a histochemical method used to detect the presence of the β-galactosidase 
enzyme, which is encoded by the LacZ gene. The enzyme hydrolyzes X-Gal into 5-bromo-
4-chloro-3-hydroxyindole that dimerizes and forms an insoluble compound with blue 
coloration. This allows the use of X-gal for identification of blue staining as an expression 
marker by placing the LacZ gene under the control of the promotor of a gene of interest. 
Since we had currently no specific antibody available that recognized the protein Kir5.1, 
localization of KCNJ16 expressing cells was studied by promotor-driven X-gal staining in 
transgenic Kir5.1-/- mice carrying the LacZ gene within the gene locus.  
3.2.3.4 Immunofluorescence 
Immunohistochemistry is a technique that is used to detect specific biomolecule targets by 
antibodies. In this method, the labelling was used with two antibodies. A primary antibody 
that specifically binds to the targeted molecule and a secondary that recognizes and binds 
the primary antibody and carries a fluorophore. The localization of the antibody was 
detected by excitation of the fluorophore in the corresponding wavelength. The cryo-
sections obtain as mentioned above, were rinsed in PBS for 5 min (two times) before and 
after incubated in 0.1% SDS solution for epitope unmasking. Afterwards, the sections were 
incubated with blocking solution (5% BSA solution) for 10 min to mitigate unspecific 
antibody binding. The antibodies (primary and secondary) were diluted in PBS solution 
containing 0,5% BSA and 0,04% Triton X-100. The sections were incubated with the 
primary antibody at 4C, in a humid chamber, overnight. Afterwards, the tissue was 
immersed in PBS for 5 min to wash the antibody that did not bind and incubated with the 
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secondary antibody for 1 h, at room temperature, in the dark. In the end of the process, 
sections were washed two times with PBS, each time for 5 min, mounted in Dako medium. 
For immunofluorescence labelling of HEK or CHO, cells were cultivated on glass cover-
slips and transfected as described in section 3.2.2. After washing in PBS, the cells were 
fixed with 3% paraformaldehyde for 10 min and once again thoroughly rinsed with PBS 
solution. The following procedure was similar to the one performed for cryo-sections. 
3.2.4 Molecular Biological Methods 
3.2.4.1 Site directed Mutagenesis 
To test the cellular effects of the KCNJ16 mutations, the Kir5.1R35Q mutant was generated 
using site directed mutagenesis. The mutation was introduced into the wildtype human 
KCNJ16 cDNA and sub cloned into plasmid pIRES CD8 (ampicillin resistance). This allowed 
the transfection of mammalian cell lines - HEK293T and CHO.  
To exchange an individual base (point mutation) in a desired cDNA, specific primers were 
designed. Primers are complementary to the template DNA around the mutation site 
allowing the hybridization with a specific DNA sequence. Two fragments carrying the base 
exchange were obtained and after insertion of the restriction sites for enzyme NotI were 
ligated into the pIRES CD8 plasmid. The length of both PCR fragments was determined by 
agarose gel electrophoresis and the desired bands were cut from the gel and purified using 
QIAquick® gel extraction kit (Quiagen) according to manufacturer’s instructions. Ligation, 
was performed by mixing 1 μL of Quick ligase, 5 μL of appropriated buffer ligase, 3 μL of 
fragment and 1 μL of vector (both the fragment and the plasmid were cut with the restriction 
enzyme for 2h at 37 ° prior to the ligation step). The ligated plasmid was transformed into 
XL1 blue E.Coli cells. Successful mutagenesis was confirmed by sequencing (SeqLab). 
Plasmid Mini Kit were used to purified the plasmid according to manufacturer’s instructions. 
Temperature Time Repetitions 
94 °C 3 min  
94 °C 30 sec 
30 cycles 
52 °C 30 sec 
72 °C 2min 20 sec 
72 °C 3 min 
10 °C ∞  
3.2.4.2. Isolation of total RNA from Kidneys 
Male and female mice tissues were used to isolate RNA. The organs were harvested after 
euthanasia and tissues were frozen in liquid nitrogen and stored at -80 ˚C. After 
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homogenization of tissues with a mortar and pestle, the result powder was used on a 
NucleoSpin RNA kit from Macherey-Nagel according to manufacturer’s instructions in order 
to isolate RNA. 
A different method to isolate RNA from mice cochlea was used. According to the protocol 
of Patil et al, 2015, the cochleae were homogenized and the cells lysed in 750 µL Trizol. 
Afterwards, the mixture was centrifuged at 12000g for 5 min, at 4 ˚C to remove bone debris. 
Trizol is a monophasic solution that solubilizes biological material and leads to denaturation 
of protein. After solubilization, the addition of 350 μL of chloroform causes a phase 
separation by centrifuging the mixture at 12000g for 15 min at 4 ˚C. Protein was extracted 
to the organic phase (lower layer─chloroform) and the RNA remained in the aqueous phase 
(upper layer).  
In order to precipitate the RNA, 350 µL of 70% ethanol were added to the aqueous phase 
and the mixture was purified using the NucleoSpin RNA kit from Macherey-Nagel according 
to the manufacturer’s instructions. To confirm the concentration of RNA the samples were 
measured in a Nanodrop spectrophotometer and stored at -80 ˚C. 
3.2.4.3 Reverse Transcription (cDNA-Synthase) 
cDNA was synthesized by reverse transcription using an RNA template obtained as 
described before. RNA was incubated with random primers at 70 ˚C for 5 minutes to 
linearize the secondary structure of RNA (Table 2). Afterwards, the mixture was placed in 
ice to allow primers to bind to RNA molecules. To this reaction mixture was added dNTP’s, 
RNAse inhibitor and M-MLV reaction buffer (see Table 3) and the mixture was vortexed and 
centrifuged. The reverse transcriptase mixture was divided in two reactions: one reaction 
with the enzyme M-MLV Reverse Transcriptase and to the other only H2O has a control for 
genomic DNA contamination in the RNA. The mixes were then incubated according to the 
protocol (see Table 4) to obtain cDNA. 
 
Table 2. Reaction mixture 
1 µg RNA 
70 ˚C for 5 
min 
Then in 4 ˚C. 
1 µL Random primer 
13 µL Free-nuclease 
H2O 
 
 
 
 
Table 3. Reverse transcription mixture 
15 µL of the previous mixture 
5 µL M-MLV Reverse Transcriptase 
Buffer (5X) 
1.25 µL dNTP-Mix 
1 µL RNAse inhibitor 
2.75 µL RNAse-free water 
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Table 4. PCR Protocol 
Temperature Time 
22 °C 10 min 
50 °C 50 min 
70 °C 15 min 
10 °C ∞ 
3.2.4.4 Quantitative Polymerase chain reaction (Real-time PCR) 
The quantitative PCR is determined indirectly by measuring the SYBR® Green fluorescent 
dye. The dye binds preferentially to the double-strand of DNA and its fluorescence intensity 
is higher when compared to the free dye. 
A SYBR® Green PCR kit and a Light-Cycler System 2.0 from Roche were used to perform 
real-time PCR. A reaction mixture containing SYBR Green, cDNA obtained from the 
previous section and sense/antisense primers (see Table below) were incubated for 5 min 
at 70 °C, before being cooled in ice for 5 min. The amplification procedure is described in 
the Table below with 40 cycles that allowed for DNA denaturation, hybridization of primers 
with DNA and elongation phase. To analyze the specificity of the primers the PCR result 
was run in a 2.5% agarose-gel. The data was normalized to the expression of the 
housekeeping gene β-actin. 
Reaction Mixture 
5 µL SYBR Green mix 
3 µL RNase free H2O 
0.5 µL sense primer (10 μM) 
0.5 µL antisense primer (10 μM) 
1 µL of cDNA 
 
Amplification 
95 ˚C 10 min   
95 ˚C 15 sec 
40 cycles 55-60 ˚C 20 sec 
72 ˚C 20 sec 
95 ˚C 5 sec   
The sequence and annealing temperature for all used primers can be found in 
Oligonucleotides (section 3.1.6). 
3.2.5 Patch Clamp Experiments of transfected cells 
The patch clamp technic allows the study of electrical currents over the membrane of the 
cell, which mainly results from the activity of ion channels.  
The amplifier used was an EPC-10 device coupled to a computer and a Powerlab Data 
Acquisition system. The software Patchmaster was used for pulse generation and data 
acquisition along with LabchartPro.  All work was acquired at room temperature, with 
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running solutions (section 3.1.8; Patch clamp Solution). The continuous bath perfusion in 
the experiments avoided cell damage by discharging K+ from the reference electrode 
(“flowing KCl electrode”). The patch pipettes used were obtained from glass capillaries to a 
resistance of about 7 MΩ. 
3.2.5.1 Patch clamp measurements in whole cell mode 
Whole cell mode recordings were performed on transiently transfected CHO cells. To 
achieve the whole cell configuration, a patch pipette (95 mM K-gluconate, 30 mM KCl, 4.8 
mM Na2HPO4 •2H2O, 1.2 mM NaH2PO4 •H2O, 5 mM Glucose, 2.38 mM MgCl2, 0.726 mM 
CaCl2, 1 mM EGTA and 3 mM ATP-Na2) was placed on the cell and the membrane was 
ruptured by applying suction to the pipette. As a result, the interior of the pipette is now 
linked to the intracellular space of the cell, which allows controlling intracellular factors.  
Using the PatchMaster software (Version V2x65), cells in the whole cell configuration could 
be measured by switching between voltage and current clamp modus in a frequency of 1.5 
Hz. In the current clamp, zero modus (CC0) the current of the whole cell was clamped to 
zero ampere for 10 seconds and the resting potential of the cell was recorded. In the voltage 
clamp modus (VC), the whole cell the voltage of the cell was clamped from -120 mV to +30 
mV in 30 mV voltage increments lasting for 2 sec and the corresponding current was 
measured.  
The liquid junction potential of the pipette solution and the bath solution (5 mM Hepes, 5 
mM glucose, 1.3 mM CaCl2, 1.6 mM K2HPO4 •3H2O, 0.4 mM KH2PO4, 1 mM MgCl2, 145 
mM NaCl) was 10 mV and corrected by the PatchMaster software. Data was acquired at a 
frequency of 0.5 kHz. 
To control for successful expression of Kir-channels, cells were superfused with bath 
solution containing 100 μM BaCl, which is a non-selective blocker of K-channels and should 
effectively reduce the conductance and depolarize the cells.  
For analysis of the whole cell recordings, current-voltage relationships were obtained by 
analyzing one representative trace of one voltage step before and under BaCl per cell using 
the Labchart Reader software. For each voltage step, averaged currents were calculated. 
The number of individual cells measured is indicated by the letter n. Experiments were 
repeated at least three times on different days.  
3.2.5.2 Patch clamp measurements in single channel mode 
Electrophysiological recordings of single channel currents allows detailed and precise 
information about the behavior of ion channels. The experiments were performed and 
carried out, at room temperature, as described before. For these experiments, HEK cells 
were chosen due to higher probability of obtaining a successful experiment when compared 
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to CHO cells (used in whole cell) and due to less likely run-down of channels in HEK cells. 
To record a single channel event a cell-attached or inside-out configuration was obtained. 
In cell-attached mode, the patch pipette is in contact with the cell membrane and after the 
seal; different holding potentials were applied to the membrane in order to measure the 
single channel conductance. Afterwards, to achieve inside-out mode the pipette was 
retracted to break off a patch of membrane and symmetrical ion concentrations on both 
sides of the patch were obtained by changing the bath solution to the solution used in the 
pipette. This made sure that the currents were evoked by voltage, from a holding potential 
of -10 mV, delivered in -10 mV increments from -120 mV to +50 mV.  
Single channel currents were recorded with an EPC-10 amplifier and analyzed with 
Labchart. The reference electrode in the bath was an Ag/AgCl pellet. The data analysis 
signals were typically low-pass filtered at 1 kHz by a Bessel filter (Patch Master). In cell-
attached experiments, the bath solution was equal to that used by whole cell experiments. 
In excised inside-out membrane patches, the solution in the bath was the same as in the 
pipette allowing for a symmetrical environment. 
3.2.6 Ca2+ Measurements with Fura-2 
Fura-2 is a fluorescence Ca2+ indicator, which allows measurement of intracellular calcium 
concentrations. The substance diffuses inside the cell as a nonpolar ester and is cleaved 
by endogenously expressed esterase regenerating the calcium indicator. The principle of 
this measurement relies on the fact that Fura-2 changes its fluorescence properties in the 
presence of Ca2+. When bound to Ca2+, Fura-2 presents an excitation maximum at 340 nm 
and in the absence of Ca2+; the maximum is at 380 nm. The cells are exposed to the 
wavelengths and the ratio of the emissions at those wavelengths is directly related to the 
amount of intracellular calcium. This is the advantage of this ratiometric method, which 
shows an independence on the dye concentration and the cell thickness. 
3.2.6.1 Ca2+ measurements in isolated DCTs 
The mice were anesthetized with isoflurane, as described before (section 3.2.3.1), and 
perfused with 10 mL digestion solution II (section 3.1.8) at pH 7.4 and 37˚C.The digestion 
solution contains collagenase II, which allows the degradation of collagen fibrils present in 
the connective tissue. The kidneys were quickly removed, sliced and transferred into 2 mL 
of incubation solution containing 1 mg/mL collagenase and swirled at 850 rpm, at 37 ˚C in 
the thermomixer. After 10 min, a 1 mL tubule suspension was transferred into 1 mL of ice 
cold sorting solution containing albumin and kept on ice. One milliliter of incubation buffer 
was added to the remaining tubule suspension, and the enzymatic reaction continued for 5 
min at 850 rpm and 37 ˚C. This procedure was repeated resulting in three tubule fractions. 
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Isolated and sedimented tubules were resuspended in ice-cold sorting solution and kept on 
ice until use. Afterwards, the tubules were transferred into the bath of an inverted 
microscope stage. The bath was thermostat controlled at 37 ˚C and a continuous perfusion 
at 3-5 mL/min was maintained by a peristaltic perfusion pump. The tubules were monitored 
and measured by video imaging (Zeiss pro v2.0 and 2.3). The experiments were performed 
on DCT, a nephron segment immediately adjacent to the glomerulus, and where either 
superfused on the basolateral side or perfused on the apical side. Superfused isolated 
tubules were transferred to a cover glass mounted in closed perfusion chamber, and 
immobilized with two glass pipettes. Perfused tubules were held by a glass pipette and 
perfused on the apical side by a concentric glass pipette system as described by Greger et 
al64. The DCTs were loaded by incubating for 20 min with fura-2 AM (5 µM) dissolved in 
control solution and 1% albumin for a better uptake into the cells and to avoid fura crystal, 
without the toxic effect of pluronic acid. After loading, the tubules were washed to remove 
non-absorbed fura-2 and measured when the ratio 340/380 was stable. Thereafter, different 
substances where tested and the response recorded on both wavelengths every 10 
seconds. The inclusion criteria depended on the ability of the cells capable of taking up the 
fura-2 and retain the dye without leak for the duration of the experiments. 
Mean fluorescence ratios before and during application of the different substances were 
calculated for single tubules using the ZEN Pro 2.3 version (Zeiss). n refers to the number 
of individual DCTs. All experiments were repeated with at least three different mice.  
The RNA isolation from the kidney tubules of the nephron was performed after kidney 
digestion and manually sorting of the tubules. The tubules were dissected based on 
morphology. The RNA isolation process was has described before (section 3.2.4.2) and the 
Quick-RNA™ MicroPrep kit (Zymo Research) was used. 
3.2.7 Plethysmography 
Respiratory function was assessed in awake and unrestrained mice using a whole body 
plethysmograph (EMKA Technologies). In total, 15 animals were investigated, 8 wildtypes 
and 7 Kir5.1-/-. Mice were placed in separated chambers and allowed to adapt to their new 
environment for 30 minutes. Baseline and recovery periods were measured at normal 
atmosphere for at least 30 min. Respiratory parameters of each condition were followed 
over a period of 30 to 60 minutes with average recordings for every minute. Hypoxia was 
induced by lowering the oxygen concentration to 10% in the chamber air supply. In these 
experiments, the oxygen was replaced by nitrogen. The animals were acclimatized for 30 
min, left under control conditions for another 30 min (21% O2) and then hypoxia was induced 
(10% O2) for 60 min after which the animals were allowed to recover. Hypercapnia was 
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induced with controlled inflation of 5% CO2 to the chambers. In these experiments, the CO2 
lead to a decrease of O2 levels. 
3.2.8 Statistics 
Data are shown in mean values ± standard error of the mean (SEM). The number of 
experiments performed for a measurement series was represented by the numbers in the 
legends of the figures (n). If not stated otherwise, data was compared using a paired or 
unpaired Student’s t-tests using the origin software after a Gaussian distribution was 
verified. A p-value of 0.05 was accepted to indicate statistical significance, which is 
indicated by an asterisk (*), a p-value <0.01 was considered to be significant (**) and a p-
value <0.001 as highly significant (***) in the respective graph. For multiple testing, the 
Bonferroni corrections were calculated. 
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4. Results 
4.1 Expression and localization of KCNJ16 
4.1.1 KCNJ16 expression in mouse tissues  
The first objective of this work was to re-visit in more detail the previously published tissue 
expression of Kcnj16 (Kir5.1) and its interaction partner Kcnj10 (Kir4.1) in mouse.65–67 The 
two channel proteins are known to form heterodimers in some, but not in all, cell types. For 
this purpose, RNA was isolated from murine tissues and tested for the expression of Kcnj16 
and Kncj10 using real-time PCR. 
 
 
Figure 6. mRNA levels of Kcnj16 and Kcnj10 in several tissues of Kir5.1+/+ mice. 
mRNA was isolated from various murine tissue and analyzed for expression of (A) Kcnj16 and (B) 
Kcnj10 (n = 3) and normalized to Actb (β-actin) mRNA levels. KCNJ16 is highly expressed in kidney 
and salivary gland while KCNJ10 is mainly expressed in brain and cochlea. Data is presented as 
mean±SEM. Abbreviation: gl=gland.  
As shown in Figure 6, Kcnj16 was expressed in several tissues, such as cochlea, stomach 
and thyroid glands. However, the kidney is the major organ of Kcnj16 expression in the 
mouse. In contrast, Kcnj10 expression was highest in the brain. Nevertheless, Kcnj16 and 
Kcnj10 were co-expressed in the kidney, cochlea and thyroid gland. 
4.1.2 Kir5.1 (Kcnj16) localization in the kidney 
To analyze the expression of Kir5.1 and Kir4.1 within the kidney in more detail, the nephron 
segments were manually sorted from enzymatically digested mouse kidneys according to 
distinct morphological criteria (Figure 7).68 After mRNA isolation, the transcript levels of 
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Kcnj16 and Kcnj10 (normalized to β-actin mRNA levels) were quantified using real-time 
PCR. 
 
 
Figure 7. Microdissected tubular segments from the mouse kidney. 
Overview of microdissected renal tubule segments sorted according to distinct morphological 
differences. Proximal tubules (PT) are long and have a smooth surface with no change in diameter. 
The early S1 segment is convoluted and might still be attached to the glomerulus (glom). The late 
S3 segment of the PT is long and straight. In contrast, the thick ascending limp (TAL) is also long 
and straight but has a smaller diameter. The distal convoluted tubule (DCT) shows strong basal 
infoldings and often a sigmoidal-formed shape. On one end, a TAL and a glomerulus might still be 
attached at the region of the macula densa (MD). On the other end, the transition into the connecting 
tubule (CNT) is characterized by the appearance of cobblestone-like principal cells. The collecting 
duct (CD) can easily be distinguished by their branching and cobblestone-like appearance. 
After isolation of tubules, mRNA from all segment was isolated and the correctness of 
sorting was confirmed by conducting a real-time PCR against several markers for each of 
the tubular segments. The following markers were used to confirm the sorting of the tubules: 
megalin, which is expressed in the proximal tubule; podocin, which is expressed in 
podocytes of the glomeruli; calbindin was used as a DCT/CNT marker; NKCC2 
cotransporter as a TAL marker and mucolipin as a collecting duct marker. After the correct 
sorting of the segments was verified (Supplemental Figure S1), the mRNA levels of Kcnj16 
(Figure 8) and Kcnj10 (Figure 9) of the isolated tubules were quantified using real-time PCR. 
For Kcnj16, the highest transcript levels were found in the DCT followed by the PT. 
However, Kcnj10 was not expressed in the PT but it was highly expressed in TAL, CD and 
co-expressed with Kcnj16 in the DCT. 
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Figure 8. Real-time PCR analysis of Kcnj16 mRNA levels in the nephron segments. 
Real-time PCR analysis of manually sorted nephron segments showed mRNA expression of Kcnj16 
in the different segments of the kidney. Expression of Kcn16 was predominantly found in the proximal 
tubule (PT) and distal convoluted tubule (DCT) while lower expression was found glomeruli (Glom), 
thick ascending limbs (TAL) and collecting ducts (CD). Graphs represent mean mRNA expression 
levels normalized to β-actin ± SEM; numbers above SEM indicate the number of mice. 
 
 
Figure 9. Real-time PCR analysis of KcnJ10 mRNA levels in the nephron segments. 
Real-time PCR analysis of manually sorted nephron segments showing mRNA expression of Kcn10 
in the different segments of the kidney. Expression of Kcn10 is predominantly found in later nephron 
segments like thick ascending limbs (TAL), distal convoluted tubules (DCT) and collecting ducts 
(CD). Low expression was found in glomeruli (Glom) and proximal tubules (PT). Graphs represent 
mean mRNA expression levels normalized to β-actin ± SEM; numbers above SEM indicate the 
number of mice. 
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The expression of Kcnj16 in PTs and DCTs was confirmed using a Kir5.1-/- mouse model, 
where a LacZ gene was placed under the control of the Kcnj16 promotor. This allowed 
assessing Kcnj16 promotor-driven X-Gal activity. Consecutive cryo-sections of transgenic 
Kir5.1-/- kidneys were prepared and either stained with X-Gal (see 3.2.3.6) or with specific 
tubule section markers (calbindin and aquaporin-2). The markers allow identification of the 
renal tubular segment (Figure 10). 
 
 
Figure 10. Expression of KCNJ16 in mouse kidney. 
Overviews of two consecutive kidneys cryo-sections of Kir5.1-/- mice that were stained either with 
antibodies against specific tubule markers (left) or with X-Gal (right). The blue X-Gal staining can be 
found throughout the cortex predominantly in proximal tubules (*) and distal convoluted tubules (▲). 
This becomes apparent when comparing stained tubules in the mirrored consecutive slide that was 
stained with antibodies against the distal convoluted tubule marker calbindin (green) or the collecting 
duct marker aquaporin 2 (red). Nuclei are depicted in blue and can be used to identify glomeruli (G), 
in which no KCN16 expression could be observed.  
Figure 10, illustrates Kcnj16 promotor-driven X-gal staining (blue coloration) in the mouse 
kidney. Through co-localization analysis, in Kir5.1-/- mouse kidneys, β-galactosidase activity 
was detected in proximal and distal convoluted tubules (DCT). This became apparent when 
Results 
-43- 
 
consecutive kidney sections were stained with DCT/CNT-marker calbindin. However, not 
all proximal or distal tubules were positive for KCNJ16 expression. Additionally, no blue 
coloration of glomeruli or connecting tubule/collecting duct (CNT/CD) stained with 
aquaporin-2 was observed.  
4.1.3 Electrophysiological experiments 
A new patient was identified with renal salt wasting with homozygous missense mutation of 
KCNJ16 gene, the mutation p.Arg35Gln (R35Q), where an arginine (Arg, R) is replaced by 
a glutamine (Gln, Q). However, a causal link between the mutation and the clinical 
phenotype could not yet be established because linkage analysis was not possible with only 
with one patient. Previously, another KCNJ16 p.Arg137Cys (R137C) mutation revealed an 
effect on membrane localization, as the trafficking of the mutant R137C was affected and 
the mutant Kir5.1 channels hardly reached the membrane.69 Therefore, the consequences 
of the new Kir5.1 mutation on the subcellular localization, membrane targeting and function 
were studied using immunofluorescence and patch clamp technique (whole cell and single 
channel experiments). 
4.1.3.1 Immunofluorescence of transfected cells 
Since Kir5.1 alone does not form a functional homomeric channel, CHO cells were co-
transfected with Kir4.1 and Kir5.1 and stained with an anti-Kir5.1 antibody to determine the 
effect of the mutation R35Q on the trafficking to the membrane and the ability of the proteins 
to form heteromeric Kir4.1-Kir5.1 channel complexes. Figure 11 shows that both proteins 
(Kir5.1wt, Figure 11 B; and Kir5.1R35Q; Figure 11 C) appear to be partially located in the 
membrane. The mutation R35Q did not seem to affect the trafficking of the protein to the 
membrane. 
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Figure 11. Immunofluorescence of Kir5.1 transfected CHO cells. 
CHO cells transfected with Kir4.1 and Kir5.1 were stained with a Kir5.1 antibody (green) and 
phalloidin (red, distribution of filamentous actin). (A) Kir5.1wt, (B) Kir4.1-Kir5.1wt and (C) Kir4.1-
Kir5.1R35Q. Both Kir5.1 forms show a partial membrane localization suggesting that both Kir5.1 
variants make heteromeric channel complexes with Kir4.1 and that the traffic of the Kir5.1R35Q mutant 
was not affected. 
4.1.3.2 Whole cell measurements 
Immunofluorescence results confirmed that the Kir5.1 mutant R35Q reaches the membrane 
of the cells and likely forms heteromers with Kir4.1. To investigate the function of the 
Kir5.1R35Q mutant, patch-clamp measurements were carried out on transfected CHO cells. 
CHO cells were co-transfected with Kir4.1 and Kir5.1 in two different stoichiometric ratios, 
a ratio of 1:1 to analyze the effect of Kir5.1 on Kir4.1-mediated currents and a ratio of 1:10, 
with a 9 fold higher concentration of Kir5.1 to avoid the formation of homomeric Kir4.1 
channels.30  
The membrane potential was measured under control conditions and after applying a Ba2+-
containing solution. Ba2+ is a divalent cation capable of reversibly blocking a broad variety 
of K+ channels.70,71 It was used to detect the activity of K+ channels and measure Ba2+-
sensitive currents. 
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Figure 12. Whole cell currents of heteromeric Kir4.1-Kir5.1 and Kir4.1-Kir5.1R35Q channels. 
CHO cells were co-transfected with Kir4.1 and (A) Kir5.1wt (n=15) or (B) Kir5.1R35Q (n=16) in a 
stoichiometric ratio of 1:1. (C) Non-transfected cells served as control cells. Current – voltage (I/V) 
curves are shown under control ( ) and external high K+ 50 mM ( ) conditions. 
Additionally, calculated Ba2+-sensitive I/V curves ( ) are shown, that were obtained in the 
presence of 100 μM Ba2+ in the bath solution. Values represent mean values ± SEM. 
Homomeric Kir5.1 channel complexes, as reported previously, did not induce measurable 
currents or hyperpolarize the membrane.39,54,55,72 Instead, Kir5.1 formed heteromers with 
Kir4.1 resulting in reduced whole-cell conductance when compared to Kir4.1 homomeric 
channels (Figure 13 A). To study the contribution of Kir5.1 to Kir4.1-mediated currents, cells 
were co-transfected with Kir4.1. The membrane voltage of cells expressing homomeric 
Kir4.1 or Kir4.1-Kir5.1 (wt or R35Q) heteromers were hyperpolarized close to equilibrium 
potential of K+ (Figure 12 and 13) when compared to non-transfected cells (-29±5 mV; 
Figure 12 C). Cells co-expressing Kir4.1-Kir5.1, in a ratio 1:1 exhibited large K+ currents 
and were strongly hyperpolarized (Figure 12 A). Similar results were obtained for the Kir4.1-
Kir5.1R35Q (Figure 12 B) channel that was undistinguishable from the K+ currents elicited 
Kir4.1 alone (Figure 13 A). These effects may be due to homomeric Kir4.1 channels that 
have a tendency to assemble. To reduce the formation of Kir4.1 homomers, cells were co-
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transfected with Kir4.1-Kir5.1 (wt or R35Q) in a ratio of 1:10 (Figure 13). As shown in Figure 
13 C and E, both heteromeric channel complexes containing Kir5.1 have smaller whole-cell 
currents when compared to homomeric Kir4.1-mediated currents (Figure 13 A). 
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Figure 13. Effect of intracellular pH on Kir4.1-Kir5.1-mediated whole cell currents. 
Whole cell currents of CHO cells co-transfected with Kir4.1 and Kir5.1 under two different pH pipette 
solutions, pH=7.2 and 6.8. Current–voltage (I/V) relationship of (A-B) Kir4.1, (C-D) heteromers 
Kir4.1-Kir5.1wt and (E-F) Kir4.1-Kir5.1R35Q (1:10) under control ( ) and K+ 50 mM ( ) 
solutions. Mean values ± SEM of whole cell conductance are shown before applying K+; after 
applying 50 mM of K+ and calculated Ba2+-sensitive currents ( ). 
Results 
-48- 
 
Application of Ba2+ (100 μM) led to depolarization of the cells due to inhibition of Kir channels 
by Ba2+ ions. As a measure of the Kir K+ currents, the Ba2+-sensitive currents were 
calculated (blue squares in charts). Expression of Kir4.1 homomeric or heteromeric 
channels induced large Ba2+-sensitive currents. However, heteromeric Kir4.1-Kir5.1R35Q 
channels displayed similar currents that were not different from the wildtype Kir4.1-Kir5.1 
heteromers suggesting that surprisingly the missense mutation did not affect the channel 
function. The conductance of the heteromeric Kir4.1-Kir5.1 channel was reported to be 
sensitive to intracellular pH, while extracellular acidification in oocyte experiments showed 
no effect on whole cell currents. To test whether intracellular pH was able to regulate Kir4.1-
Kir5.1 channels in CHO cells, the pipette solution was changed from pH 7.2 to more acidic 
pH 6.8 (Figure 13 B, D and F). Surprisingly, the heteromeric Kir4.1-Kir5.1 channels, either 
Kir5.1wt or Kir5.1R35Q, exhibited currents similar to those under control conditions. This is in 
contrast to previous reports showing an inhibition of heteromeric channel activity at acidified 
intracellular pH.55,58,73  
The apparent lack of sensitivity towards intracellular pH change could be explained by i) 
lack of heteromeric channel assembly or ii) insufficient diffusion of the pipette solution into 
the cells allowing pH-regulating mechanism of the cell to keep intracellular pH rather 
constant. To test the first hypothesis, single channel experiments were performed allowing 
to assess the presence or absence of heteromers according to their specific single channel 
properties. 
4.1.3.3 Effects of Kir5.1 mutation at single channel level 
The mutant Kir4.1-Kir5.1R35Q channels showed K+ currents in whole cell experiments similar 
to wildtype Kir4.1-Kir5.1. To assess whether transfection of both Kir4.1 and Kir5.1 resulted 
in heteromeric channels assembly, single channel recordings were made of transfected 
HEK cells. Heteromerization between Kir4.1 and Kir5.1 is known to produce channels with 
characteristic single channel properties. In the cell-attached configuration with a bath-like 
pipette solution, Kir4.1-expressing cells (Figure 14 A) showed large inwardly rectifying 
currents with clear single channel levels and no sub-states. In line with previous reports, 
the conductance at 0 mV was ~30 pS. Additionally, homomeric Kir4.1 exhibited a high open 
probability (70-80%).30 
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Figure 14. Representative single channel trace of HEK cells transfected with Kir4.1 and Kir4.1-
Kir5.1wt. 
Single channel recordings of transfected HEK cells in the cell-attached configuration at voltage 
clamps of 0, -30 and -60 mV. (A) Homomeric Kir4.1 channels showed clear single channel levels 
and high open probability while (B) Kir4.1-Kir5.1wt heteromeric channels showed larger channel 
conductance and additional sub-states (s1-s2). Additionally, open probability of Kir4.1-Kir5.1wt was 
lower compared to Kir4.1 homomeric channels. 
In contrast, Kir4.1-Kir5.1wt heteromers produced higher single channel current amplitudes 
when compared to Kir4.1 homomers. In single channel recordings of Kir4.1-Kir5.1 (Figure 
14 B) and Kir4.1-Kir5.1R35Q (Figure 15 A) heteromers regularly displayed sub-states of 
smaller sizes, as reported previously.56 The amplitude of Kir4.1-Kir5.1R35Q did not differ from 
the ones of Kir4.1-Kir5.1 channels, which exhibited large current amplitudes and sub-states 
activity. During the time of the recording heteromeric Kir5.1wt or Kir5.1R35Q were not as active 
when compared to homomeric Kir4.1 channels. 
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Figure 15. Electrophysiological single channel analysis of heteromeric Kir4.1-Kir5.1R35Q 
channels. 
Single channel recording of transfected HEK cells in cell-attached configuration at voltage clamps of 
0, -30 and -60 mV. (A) Kir4.1-Kir5.1R35Q channels showed higher conductance with characteristic 
sub-states but reduced open probability. (B) Single channel current-voltage relationship of 
measurements in inside-out patch configuration with symmetrical solutions presented a 32 pS 
conductance for Kir4.1, 56.6 pS for Kir4.1-Kir5.1wt and 56.7 pS for Kir4.1-Kir5.1R35Q.  
Figure 15 B shows single channel recordings of homomeric Kir4.1, heteromeric Kir4.1-
Kir5.1wt and Kir4.1-Kir5.1R35Q in the inside-out configuration. The solution used in the bath 
and the pipette were the same in order to have symmetrical conditions to circumvent 
concentration differences as a driving force for K+ ions. Single channel conductance was 
calculated between membrane voltage of -10 and -80 mV, and heteromeric Kir4.1-Kir5.1 
and Kir4.1-Kir5.1R35Q presented similar conductance (~60 pS), which was higher than that 
obtained for homomeric Kir4.1 of ~30 pS. 
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Figure 16. Sensitivity of Kir4.1-Kir5.1 channels to intracellular pH. 
Representative inside-out patch recordings of transfected HEK cells. Channel activity was evoked 
by voltage command to -70 mV during patch perfusion with control solution with pH7.2. Blue arrows 
indicate a change to pH 6.0 and consequent channel inhibition of (A) Kir4.1-Kir5.1wt and (B) Kir4.1-
Kir5.1R35Q and recovery after adding the solution with pH 7.2 (green arrow). 
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To confirm the effect of intracellular acidification on the heteromeric channels activity from 
excised membrane patches were recorded. Figure 16 shows that exposure of the 
intracellular surface of the patch to a solution of pH 6.0 (blue arrow) rapidly reduced the 
activity of these channels. This effect was reversible after adding the solution with pH 7.2 
(green arrow) with recovery of the channels activity. These results clearly demonstrate that 
intracellular acidification inhibits both the Kir4.1-Kir5.1R35Q and the Kir4.1-Kir5.1wt  
heteromeric channels. 
4.2 Kir5.1-/- Mouse Model 
The electrophysiological analysis of the Kir5.1R35Q mutation did not reveal a loss-of- or gain-
of-function, which still might be explained by the lack of physiological conditions in 
heterologous expression systems. Nevertheless, expression and localization of Kir5.1 in the 
kidney as well as the tubulopathy of the patient with the Kir5.1R35Q mutation still suggested 
a role of Kir5.1 in tubular transport. More specifically, the hypokalemic acidosis in 
combination with hypercalciuria and hypermagnesuria observed in this patient suggested 
an impairment of the distal tubules. A renal tubular acidosis resulting from severe proximal 
tubular dysfunction would likely present with phosphaturia, glycosuria, aminoaciduria, 
uricosuria, and tubular proteinuria as well. Additionally, previous publications of a Kir5.1-/- 
mouse model from Paulais et al. already showed that Kir5.1-/- mice developed hypokalemic 
acidosis although no hypocalcaemia or hypomagnesemia was observed.54 The functional 
importance of Kir channels in ion transport in the DCT has also been recognized by 
mutations in Kir4.1 which cause EAST/SeSAME syndrome and are known to have 
electrolyte imbalance with hypokalemia, metabolic alkalosis, hypomagnesemia and 
hypocalciuria.16,25,30,33,52 
Besides a role in renal electrolyte balance, Kir5.1 was also suggested to be involved in the 
development of hypertension. According to Palygin et al.74 expression of Kir5.1 was 
upregulated after a high salt diet (4% NaCl) which correlated between the development of 
salt-sensitive hypertension and basolateral K+ channel function in Dahl salt-sensitive rats.  
Based on those previous studies, we analyzed the electrolyte excretion as well as blood 
parameters in our own Kir5.1-/- mice as well as the effects of a high salt diet (4% NaCl) in 
this model.  
4.2.1 Basal electrolyte excretion of adult mice 
To investigate the importance of Kcnj16 deletion on electrolyte balance and K+ homeostasis 
in the body and taking into account the results from Palygin et al. we examined electrolyte 
excretion in adult (3-4 months) control (n = 20) and Kir5.1-/- mice (n = 19) of both genders.74  
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Basal electrolyte excretion was determined by collecting spot urine at least four times under 
control diet and measuring the electrolytes by ion chromatography. Since the concentration 
of the ions in the urine depends strongly on urine concentration (i.e. water reabsorption), 
electrolytes were normalized to creatinine. Creatinine is a breakdown product of creatine 
phosphate in muscles, freely filtered in the glomerulus and hardly reabsorbed or secreted 
along the nephron and is therefore usually excreted into the urine at a constant rate and 
used to normalize the values. Creatinine levels had a tendency to be lower in the Kir5.1-/- 
mice, but Kir5.1-/- mice were significantly smaller (21.69±1.24 g) when compared to the 
wildtype (26.30±0.90 g). Thus, when we normalized the absolute creatinine excretion 
(corresponding to creatinine production) to the body weight similar levels of absolute 
creatinine excretion were observed between the groups. Henceforth, all urinary electrolytes 
were normalized to creatinine concentrations. 
 
Figure 17. Normalized electrolyte excretion of mice during standard food. 
(A) Electrolyte excretion of Kir5.1-/- (n = 19) and control Kir5.1+/+ (n=20) mice under standard diet. All 
ions concentrations were normalized to creatinine concentration in urine and presented as [mM 
ion/mM Creatinine]. (B) Table displaying electrolyte excretion values presented in graph. Kir5.1-/- 
mice excreted higher amounts of measured ions like SO42-, K+ and Mg2+. Statistical analysis was 
performed with an unpaired Student’s t-test and the level of significance is provided in the table (B). 
After Bonferroni corrections, p-values ≤ 0.006 were accepted as significantly different (§). 
Under control conditions, the normalized electrolyte excretion of mice showed similar results 
for both groups of animals in Cl-, PO43- and Na+, NH4+ and Ca2+ excretion. However, for Mg2+ 
and K+ there were significant differences between the two groups with Kir5.1-/- animals 
showing a higher excretion of those electrolytes in the urine. In Figure 17, the same values 
are presented in the table. K+ and Mg2+ ions were excreted at higher levels into the urine by 
the knockout animals suggesting hypokalemia and hypermagnesuria, which is in agreement 
with the phenotype displayed by the human patient. 
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4.2.2 Effect of amiloride on electrolyte excretion levels 
Considering the hypokalemia displayed by the human patient and the mice, we investigated 
the effect of the K+-sparing diuretic amiloride. Amiloride is a blocker of the epithelium sodium 
channel ENaC, which mediates sodium reabsorption in the late DCT (DCT2), CNT and CD 
and therefore promotes the loss of Na+ and reduces K+ secretion into the urine. Urine 
samples from animals (Kir5.1+/+, n = 12 and Kir5.1-/-, n = 9) kept in metabolic cages were 
collected for 6h at control conditions and 6h after amiloride injection. 
As depicted in Figure 18, the mice showed increased urinary Na+ and decreased K+ 
excretion 6h after amiloride injection (5 μg/g BW i.p). The response was similar in both 
groups (Figure S2) indicating that ENaC-mediated Na+ absorption was not altered by 
deletion of Kir5.1. The small effect of amiloride could also be due to the salt supplementation 
of the water (see Method section for details), 24h before the experiment, given to the mice. 
Nevertheless, the results display a tendency of Kir5.1-/- to have a higher amiloride-sensitive 
K+ excretion. In light of these results, amiloride could be used to normalize plasma K+ in 
hypokalemic human patients suffering from a Kir5.1 defect. 
 
Figure 18. Effect of amiloride on normalized electrolyte excretion of mice. 
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Electrolyte excretion of Kir5.1-/- (n = 19, ■) and control Kir5.1+/+ (n=20, □) mice under standard diet. 
All ions concentration were normalized to creatinine concentration in the urine are presented as [mM 
ion/mM Creatinine]. (A) Cl-, (B) Na+, (C) K+. Statistical analysis was performed with an unpaired 
Student’s t-test. 
4.2.3 Effect of high Na+ diet on electrolyte excretion levels 
The role of Kir5.1 in the development of hypertension was investigated by Palygin and co-
workers. They created a Dahl salt-sensitive Kir5.1 deficient rat model that exhibited a renal 
phenotype reminiscent of SeSAME/EAST and Kir4.1 deletion: salt wasting, 
hypomagnesemia, and hypokalemia.74 Interestingly, the absence of Kir5.1 resulted in 
prominent retention of Kir4.1 in the cytosol of DCTs suggesting improper translocation of 
Kir4.1 in the absence of Kir5.1 in rats. This is the opposite of the marked upregulation of 
plasma membrane Kir4.1 in normotensive mice lacking Kir5.1.54 To determine whether 
improper Kir4.1 translocation is a common feature in hypertension or whether it is a feature 
only found in rat models, we induced a high salt stress in adult (3-4months) control Kir5.1+/+ 
(n = 8) and Kir5.1-/- mice (n = 10). The mice were feed a high Na+ (HNa) diet for 15 days, 
which is commonly used to induce hypertension in C57BL6/J mice.75,76 Blood was taken 
seven days before the start of the diet to allow the mice to recover. 
After the control period, Kir5.1+/+ and Kir5.1-/- mice were fed a high salt diet (4% NaCl). 
During the diet, urine samples were collected. At the end of the diet, blood was collected 
again. Figure 19, shows the time course of the normalized electrolyte excretion under high 
salt diet. Day 0 represents the mean excretion before the experimental diet. 
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Figure 19. Normalized excretion of various electrolytes from Kir5.1-/- and control mice under 
high salt (4%) diet. 
Excretion of (A) Cl-, (B) PO43-, (C) SO42-, (D) Na+, (E) NH4+, (F) K+, (G) Mg2+ and (H) Ca2+ in the urine 
were investigated during the high Na+ diet. All values were normalized to creatinine. The day 0 
corresponds to the mean excretion before the start of the diet. During the course of the diet, 
electrolyte loss in Kir5.1-/- mice become more pronounced which suggests an impaired adaptation 
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mechanism in the Kir5.1-/- mice. Data represents mean values ± SEM. Statistical analysis was 
performed with an unpaired Student’s t-test between the groups. 
Kir5.1-/- mice display a higher excretion of ions in the urine during the diet when compared 
to Kir5.1+/+ mice. As expected, control animals also display an increased excretion of Na+ 
and Cl- in response to the high Na+ diet. It is noticeable, that from day 8 to the end of the 
diet Kir5.1-/- mice excreted statistically significant higher amounts of ions to the urine (Table 
S1). At the end of HNa diet, urinary excretion of all analyzed electrolytes was significantly 
elevated in Kir5.1-/- animals when compared to wildtype (Figure 20) suggesting an impaired 
adaptation capacity in the Kir5.1-/- mice. 
 
Figure 20. Normalized excretion of various electrolytes from Kir5.1-/- and control mice after 
high salt (4%) diet. 
(A) Electrolyte excretion of Kir5.1-/- (n = 10) and Kir5.1+/+ (n=8) mice subjected to HNa diet (16 day). 
All ions concentration were normalized to creatinine concentration in urine and presented as [mM 
ion/mM creatinine]. (B) Table with electrolyte excretion values presented in graph. Kir5.1-/- mice 
excrete higher amounts of all measured ions suggesting a tubular disorder. Data represents mean 
values ± SEM. Statistical analysis was performed with an unpaired Student’s t-test and the level of 
significance is provided in the table (B). After Bonferroni corrections, p-values ≤ 0.006 were accepted 
as significantly different (§). 
Analysis of urine excretion at the end of HNa diet revealed a salt-wasting phenotype in 
Kir5.1-/- mice with a higher excretion of electrolytes in the urine. However, K+, Na+ and Cl- 
were the major electrolytes excreted (Figure 20). 
Even though Kir5.1-/- animals displayed a higher loss of ions into the urine no significant 
alteration was observed in mice weight (Figure 21 B). Both groups displayed similar weight 
with small fluctuations throughout the 16 days subjected to HNa diet. Creatinine 
concentration values, even though not significantly different revealed a similar pattern since 
at day 8 there seemed to be a dilution of the urine in both groups (Figure 21 A). 
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Figure 21. Creatinine values and weight of Kir5.1+/+ and Kir5.1-/- mice during high salt (4%) 
diet. 
(A) Creatinine concentration values and (B) body weight of Kir5.1+/+ ( ) and Kir5.1-/- ( ) 
animals throughout the HNa diet. The day 0 corresponds to the time before the diet (control). Data 
represents mean values ± SEM. Statistical analysis was performed with an unpaired Student’s t-test 
between the groups. 
4.2.4 Measurement of electrolytes in blood samples 
To analyze the phenotype of Kir5.1-/- animals and taking into account the results obtained 
in electrolytes excretion, blood samples before and after high Na+ diet were measured. 
Venous blood from the facial vein of conscious Kir5.1+/+ and Kir5.1-/- mice was analyzed for 
pH, hematocrit, gas contents and concentrations of ions Na+, K+, HCO3-, Ca2+ and Mg2+ by 
a blood gas analyzer. Some parameters were calculated from measured values, i.e. HCO3- 
and base excess (BE). Blood was collected before and after the HNa diet and results are 
presented in Figure 22. 
Before the HNa diet, most blood parameters were similar in both genotypes. However, 
blood [K+], [Na+] and partial pressure of carbon dioxide (pCO2) were significantly lower in 
Kir5.1-/- mice. These results are largely in agreement with observations of Paulais and 
coworkers who observed a hypokalemic acidosis. The lack of overt acidosis in our model 
could be explained by the reduced pCO2 levels compensating the acidosis.  
After the HNa diet, Kir5.1-/- animals were still hypokalemic with higher [HCO3-] and pCO2 
levels and a slight increase in BE (more positive values) and no change in pH. In Kir5.1+/+, 
Na+, K+, HCO3- did not change with high Na+ diet. BE significantly increased (more positive), 
pCO2 values lowered with an increase of pH. Hematocrit, [Ca2+] and [Mg2+] concentrations 
in both group of animal were not altered before and after the diet (Figure S3). 
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Figure 22. Effects of high salt diet on blood parameters of Kir5.1+/+ and Kir5.1-/-. 
(A) Na+, (B) K+, (C) HCO3-, (D) BE (presented as negative values), (E) pCO2, (F) pH, (G) Mg2+ and 
(H) Ca2+ were analyzed by blood-gas analyzer of blood samples obtained from facial vein of 
conscious  Kir5.1+/+ (□; n = 8) and Kir5.1-/- (■; n=10) mice. Kir5.1-/- mice presented hypokalemia, high 
[HCO3-] and pCO2 levels with no change in pH and a slight increase in BE. Data represents mean 
values ± SEM. Statistical analysis was performed with a paired Student’s t-test between before and 
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after the diet for Kir5.1-/- and for Kir5.1+/+. In addition, an unpaired Student’s t-test between Kir5.1-/- 
and Kir5.1+/+ (*, p≤0.05; **, p≤0.01; *** p≤0.001) was calculated. 
4.2.5 Respiratory response of Kir5.1-/- 
In the previous section, analysis of blood parameters suggested that Kir5.1-/- mice might 
have compensated a metabolic acidosis by increasing respiration. According to previous 
publications, Kir5.1 was proposed as being involved in respiratory response. To examine 
ventilatory responses upon hypoxia and hypercapnia in conscious freely moving Kir5.1+/+ (n 
= 8) and Kir5.1-/- (n = 7) mice were assessed by whole body plethysmograph. Kir5.1-/- mice 
were expected to have a decreased ventilatory response to hypoxia and hypercapnia due 
to the possible role of Kir5.1 in mediating respiratory responses. The animals were placed 
in recording chambers, which were flushed continuously with a mixture of 79% nitrogen and 
21% oxygen at room temperature. Levels of O2 in the chamber were monitored using O2 
sensor (Oxydig). The mice were allowed to acclimatize for at least 30 min to the chamber 
at control conditions (21% O2, 79% N2) before measurements of baseline respiration were 
recorded.61  
Under control conditions, main breathing parameters were similar in the two genotypes. 
When exposed to hypoxic conditions (10% O2 in the inspired gas mixture; Figure 23) both 
Kir5.1+/+ and Kir5.1-/- mice increased their breathing frequency (fR) and minute volume (MV), 
the total volume breathed in one minute. The overall ventilatory response of the Kir5.1-/- 
animals were similar to that of the Kir5.1+/+. The Kir5.1-/- displayed only a slightly lower 
response in peak expiratory flow (PEF, Figure 23) as a result of lower O2 presence in the 
air, though the differences were not significant. 
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Figure 23. Ventilatory responses to hypoxia in Kir5.1+/+ and Kir5.1-/- mice. 
Ventilatory responses to hypoxia (10% O2 in the inspired air) in conscious Kir5.1+/+ (□; n=8) and 
Kir5.1-/- (●; n=7) mice. Kir5.1-/- and Kir5.1+/+ mice increased their breathing frequency in response to 
hypoxia. However, the overall responses were similar in both groups. Data is presented as means ± 
SEM. Unpaired Student’s t-test was used to compare respiratory parameters between both 
genotypes at hypoxia. Abbreviations: RT, relaxation time; fR, respiratory rate; MV, minute volume; 
TV, tidal volume; PIF, peak inspiratory flow; PEF, peal expiratory flow; T i, inspiratory flow and Te, 
expiratory time. 
Animals exposed to hypercapnia (5% CO2) were also exposed to hyperoxic conditions. In 
this series of experiments, mice were left in the chamber to acclimatize, then they were 
exposed to 30 min of normoxia (21% O2) and 30 min in hyperoxic conditions (100% O2) to 
obtain baseline respiratory values. Afterwards, 5% CO2 was added to the chambers (in 95% 
O2). The respiratory responses evoked by hypercapnia in Kir5.1-/- (high levels of inspired 
CO2) increased respiratory frequency (fR) as well as tidal volume (TV). The increase in 
minute volume was mainly caused by an increase of TV. Again, the overall response to 
hyperoxic hypercapnia was similar in Kir5.1-/- (n = 8) and their wildtype counterparts (n = 7; 
Figure 24). 
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Figure 24. Ventilatory responses to hyperoxic hypercapnia in Kir5.1+/+ and Kir5.1-/- mice. 
Ventilatory responses to levels of hyperoxic hypercapnia (100% O2 in the inspired air and 5% CO2) 
in conscious Kir5.1+/+ (□; n=8) and Kir5.1-/- (●; n=7) mice. Kir5.1-/- and Kir5.1+/+ mice increased their 
breathing frequency and minute volume in response to hyperoxic hypercapnia. However, the overall 
responses were similar in both groups. Data are presented as means ± SEM. Unpaired Student’s t-
test (corrected for multiple testing) was used to compare respiratory parameters between both 
genotypes at hypercapnia. RT, relaxation time; fR, respiratory rate; MV, minute volume; TV, tidal 
volume; PIF, peak inspiratory flow; PEF, peal expiratory flow; Ti, inspiratory flow and Te, expiratory 
time. 
4.2.6 Ca2+ measurements on isolated tubules 
Terker and coworkers already proposed that the DCT is able to sense varying plasma K+ 
concentrations and to translate it into inhibition of Na+ uptake via the NCC. Consequently, 
the Na+ load to downstream segments of the nephron, i.e. connecting tubule and collecting 
duct, increases. High Na+ load in those segments allows K+ secretion to run at maximal 
rates in order to normalize plasma K+ (Figure 3).26 In their model, the “messenger” 
controlling NCC activity is intracellular Cl-, which controls the Cl--sensitive kinases of the 
WNK1/SPAK/OSR family which in turn control NCC activity and membrane localization of 
NCC through phosphorylation. In addition to the WNK–SPAK pathway, several other 
proteins were identified to control NCC, including parvalbumin, serum and glucocorticoid-
inducible kinase Sgk1, ubiquitin ligase Nedd4–2, and protein phosphatase 4 among 
others.13,77 We hypothesized, based on these data, that besides the intracellular Cl- other 
“second messengers” might be activated in response to alterations of plasma K+ levels. 
Here, we tested whether Ca2+ signals might also be implicated in basolateral K+ sensing. 
Since Kir5.1 is expressed together with Kir4.1 in the DCT and was shown to be important 
for the maintenance of DCT’s basolateral membrane potential, the main goal in this chapter 
was to test if Kir5.1 deletion influences the ability of DCTs to sense K+ concentrations 
variations and to translate it into variations of intracellular Ca2+ as a second messenger. 
4.2.5.1 Superfused DCT tubules 
To measure Ca2+ signals in isolated tubules, the tubule suspension was transferred to a 
closed perfusion chamber and one DCT was selected based on distinct morphological 
criteria like strong basal infoldings and often an S-formed shape with varying diameter. 
4.2.5.1.1 Calibration of fura-2 fluorescence ratios on isolated DCTs 
As depicted in Figure 25 C and D, in tubules from Kir5.1+/+ and Kir5.1-/- animals an increase 
in Ca2+ levels in response to ionomycin (Ion) and a slight decrease after adding a Ca2+-free 
solution was observed. Ionomycin was used in order to calibrate the fura-2 fluorescence 
signals. As an ionophore, ionomycin, permeabilized the cell membrane and increased the 
levels of [Ca2+]i due to Ca2+ influx across the plasma membrane and its ability to induce the 
release of cytosolic Ca2+ from cytosolic stores. However, the response of tubules to 
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ionomycin was highly variable and – due to this large scattering – not statistically significant. 
The use of a Ca2+-free solution, with the aim of strongly lowering intracellular Ca2+, was also 
not satisfactory and it was hardly possible to lower the fura-2 ratio bellow basal values 
(Figure 25). Due to these technical difficulties, the use of the Grynkiewicz equation for 
calculating absolute Ca2+ was considered not appropriate. Therefore, raw data (fura-2 
ratios) are presented in the following experiments. 
 
Figure 25. Effect of ionomycin on calcium signals in isolated murine DCTs. 
Mean values of maximal fura-2 ratios during superfusion with ionomycin (Ion, 10 μM) in (A) Kir5.1+/+ 
and (B) Kir5.1-/- distal convoluted tubules (n=4; tubules). Superfusion of DCTs with ionomycin 
induced a Ca2+ influx and store release of Ca2+, as evidenced by increase of the ratio 340/380. 
Representative traces of isolated murine DCTs of (C) Kir5.1+/+ and (D) Kir5.1-/- mice. Traces 
represent mean of ROIs ± SEM. Paired Student’s t-test was used to analyze between basal and 
ionomycin and ionomycin and Free Ca2+ solution of each group of animals(*, p≤0.05; **, p≤0.01; *** 
p≤0.001). Numbers above bars represent the number of individual DCTs.  
4.2.5.1.2 Effects of extracellular K+ on intracellular Ca2+  
The ability of the DCTs to react to extracellular K+ concentrations was accessed by 
superfusion of the DCTs with solutions with low K+ concentration (LK; 1 mM) compared to 
control solution (3.6 mM K+). The change between physiological K+ concentrations (control) 
to LK caused a reversible increase in [Ca2+]i. As it can be observed in Figure 26, lowering 
K+ concentration in both Kir5.1+/+ (A) and Kir5.1-/- (B) DCTs increased Ca2+ compared to 
basal conditions. However, we did not observe a difference between wildtype or Kir5.1-/- 
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mean response (unpaired student’s t-test; p-value 0.409) suggesting that Kir5.1 is not 
essential for sensing of K+. 
 
Figure 26. Effect of low K+ on Ca2+ signals of isolated murine DCTs. 
Mean values of maximal fura-2 ratios 340/380 during superfusion with low K+ (1 mM) in (A) Kir5.1+/+ 
(n=13; tubules) and (B) Kir5.1-/- (n=16; tubules) murine DCTs. Superfusion of DCT with low K+ 
induced increase of intracellular Ca2+ indicating that DCTs are able to sense changes in basolateral 
K+ and to translate it into a Ca2+ signal. Representative traces from isolated murine DCTs of (C) 
Kir5.1+/+ and (D) Kir5.1-/- mice superfused with LK solution.  Paired Student’s t-test was used to test 
for the statistical difference between basal and LK of each group of animals. Traces represent mean 
of at least 3 ROIs ± SEM. 
DCTs superfused with high K+ (HK; 10 mM) showed the opposite effect, leading to a 
decrease in [Ca2+]i, however the magnitude of the effect was small and not significantly 
different (Figure 27).The results obtained suggested that DCTs are indeed capable of 
sensing changes in K+ concentration and translate those changes into variations of the 
second messenger Ca2+. 
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Figure 27. Effect of High K+ (10 mM) on Ca2+ signals of isolated murine DCTs. 
Mean values of maximal fura-2 ratios 340/380 during superfusion with high K+ (10 mM) in Kir5.1+/+ 
murine DCTs. Superfusion of DCT with high K+ did not induce decrease of intracellular Ca2+ and the 
change was not statistically different. Paired Student’s t-test was used to analyze between basal and 
HK Kir5.1+/+ animals (n = 20). 
4.2.5.1.3 Effects of extracellular Ba2+ on intracellular Ca2+ 
The previous set of experiments revealed that intracellular Ca2+ activities of DCTs are 
influenced by varying extracellular K+. However, Kir5.1 deficient tubules showed the same 
mean increase in Ca2+ when K+ concentrations were lowered indicating that Kir5.1 is not an 
indispensable component of the K+ sensor in DCTs. However, the effects might be mediated 
by the close homologue Kir4.1. To study whether the effect of extracellular K+ in the DCT 
was dependent of Kir channels, Ba2+, a reversible blocker of K+ channels was used. As can 
be shown in Figure 28, a strong increase in the ratio occurred when Ba2+ was applied. This 
change in fluorescence ratio may either be the result of Ba2+ binding to fura-2 (mimicking 
Ca2+) and/or the result of a rise of [Ca2+]i , induced by Ba2+-induced depolarization of the 
membrane.78 The effect of Ba2+ resulted in a similar rise of the fluorescence in Kir5.1+/+ and 
Kir5.1-/- isolated DCTs. 
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Figure 28. Effect of Ba2+ (5 mM) on Ca2+ signals of isolated murine DCTs. 
Mean values of maximal fura-2 ratios during superfusion with Ba2+ (1 mM) in (A) Kir5.1+/+ (n=13; 
tubules) and (B) Kir5.1-/- mice (n=16; tubules). Superfusion of DCTs with Ca2+ lead to an increase of 
intracellular Ca2+ as can be seen by the increased 340/380 ratio. Representative tracing of isolated 
murine DCTs of (C) Kir5.1+/+ and (D) Kir5.1-/- mice superfused with Ba2+. Traces represent mean of 
at least three ROIs ± SEM. Paired Student’s t-test was used to test for statistical difference between 
basal and Ba2+ of each group of animals. 
Even though Ba2+ itself led to an increase in fura-2 ratio, the effect of low extracellular K+ 
(LK) under Ba2+ conditions was studied. In the presence of Ba2+, no LK-induced rise of 
[Ca2+]i was observed (Figure 29). However, the LK solution did result in a rise of [Ca2+]i after 
Ba2+ was washed out suggesting that Kir channels might be involved in sensing altered 
basolateral K+ conditions in the DCT. 
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Figure 29. Effect of LK in the presence of Ba2+ inhibitory conditions on Ca2+ signals of isolated 
murine DCTs. 
(A) Mean values of maximal fura-2 ratios 340/380 during superfusion with LK in the presence of Ba2+ 
in Kir5.1+/+ murine DCTs (n= 12; tubules). (B) Representative tracing of isolated murine DCTs 
superfused with Ba2+ + Low K+. Superfusion of DCT with low K+ in the presence of Ba2+ did not 
induced an increase of intracellular Ca2+ suggesting that the increase of [Ca2+]i when LK is applied 
was mediated by K+ channels. Trace represents mean of at least three ROIs ± SEM. This experiment 
was done by Dr. Anna-Lena Forst and bachelor student Alexander Fischer. 
4.2.5.2 Perfused DCT tubules 
Previous experiments suggested that extracellular K+ concentrations affect cytosolic Ca2+ 
activity of DCTs and that this Ca2+ might contribute to the K+-sensing mechanisms of these 
cells. However, the superfusion of the tubules might also affect luminal K+ concentrations 
and the change in intracellular Ca2+ might reflect a mixed response to variations in 
basolateral and apical K+ concentrations. To test whether the basolateral and/or apical 
membrane of DCTs responds to changes in extracellular K+ concentrations tubules were 
transferred to the bath on a heated (37 °C) microscope stage and DCTs were perfused 
using a concentric glass pipette system.  
To be able to control successful apical perfusion of the tubules with LK solution, the 
fluorescence dye Cy5 was added to the LK solution and Cy5 fluorescence was measured 
through the experiment. 
Figure 30 shows the effect of K+ concentration on [Ca2+]i levels. A rise in intracellular Ca2+ 
was only observed when basolateral, but not apical, K+ was reduced from 3.6 to 1.0 mM. A 
successful perfusion of the LK-solution on the apical side was confirmed by the presence 
of a clear peak in Cy5 fluorescent (Figure 30 B). 
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Figure 30. Effect of low K+ concentrations on the apical and basolateral side on Ca2+ activity 
of isolated murine DCTs. 
(A) Representative trace of isolated perfused DCT (n=7; DCT tubules) of a Kir5.1+/+ mice with low K+ 
solution present either on the apical or the basolateral side. A rise in intracellular Ca2+ (fura-2 ratios) 
was only observed when basolateral K+, but not apical K+, was reduced from 3.6 to 1.0 mM. Traces 
represent mean of at least 3 ROIs. (B) Corresponding trace of Cy5 fluorescence present in the apical 
low K+ solution indicated successful apical perfused with low K+ solution. 
Figure 31 A summarizes the findings of changing apical and basolateral K+. The data results 
from seven tubules (n=7) and revealed that apical low K+ solution did not affect intracellular 
Ca2+ activity. However, altering basolateral K+ in the same experiments resulted in a 
significant increase in [Ca2+]i. These results clearly suggest that only varying basolateral, 
but not apical, K+ concentrations affects [Ca2+]i signals in the DCT. 
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Figure 31. Mean values of maximal fura-2 ratios during perfusion and superfusion with low K+ 
in isolated murine Kir5.1+/+ DCTs. 
(A) Mean values (n=7 tubules) during apical and basolateral application of K+ (1 mM) in Kir5.1+/+ 
DCT. (B) Morphological aspect of a DCT perfused by a concentric glass pipette. Paired Student’s t-
test was used to analyze between 3.6 and 1.0 mM K+ in the apical or basolateral sides. 
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5. Discussion 
5.1 Kcnj16 expression 
Kir4.1 (KCNJ10) and Kir5.1 (KCNJ16) channels belong to the inwardly rectifying potassium 
channels family and mediate important K+ conductances in brain, kidney and other tissues. 
In contrast to Kir4.1, Kir5.1 is unable to form functional homomeric channels.39 Kir5.1 
channels were first cloned from brain and high expression was reported in kidney, stomach, 
brain, pancreas and thyroid gland.10,54,65,79 In the distal nephron, especially in the distal 
convoluted tubule, Kir5.1 associates with Kir4.1 to form functionally important basolateral 
K+ channels whose activity to salt transport in this segment is depending on. 
The expression patterns of Kcnj10 and Kcnj16 were assessed by real-time PCR on wildtype 
mouse tissues. Besides high expression in kidney, brain, stomach and thyroid gland, we 
also found expression of Kcnj16 in the cochlea. The expression pattern of Kcnj10 showed 
some overlap but also differences, e.g. Kcnj10 is weakly expressed in the stomach but at 
higher levels in the brain. This clearly suggest that Kir5.1 and Kir4.1 form heterodimers only 
in some tissues (e.g. in the distal convoluted tubules (DCT) of the kidney), but not (or less) 
in others (e.g. stomach and brain; Figure 6). Using Kcnj16 promotor driven X-Gal staining 
of Kir5.1-/- mice (Figure 10) and manual sorting of enzymatically digested tubules, we found 
KCNJ16 expression in the proximal tubule (PT) and DCT while KNCJ10 was only found in 
the distal parts of the nephron but not the PT (Figure 8 and 9). These findings are in 
agreement with the above mentioned studies showing colocalization of Kir4.1 and Kir5.1 in 
the basolateral membrane of DCT.50,55 These results strongly suggest that Kir5.1 may 
cooperate with other channels in the proximal tubule in order to form functional channels. A 
likely candidate would be the close homolog Kir4.2 (KCNJ15), which was found to interact 
with Kir5.1 in renal epithelia.57 
5.2 Role of KCNJ16 in the kidney 
Mutations in the KCNJ10 gene are causative for the autosomal recessive EAST/SeSAME 
syndrome, a complex disorder with a tubulopathy as renal manifestation. Unlike KCNJ10, 
no published report is yet available linking a renal pathology to mutations in the KCNJ16 
gene. However, Prof. Dr. Martin Konrad in University Münster, has identified in a single 
patient, suffering from renal salt wasting, hypokalemia and acidosis a homozygous 
c.104G>A mutation (NCBI Reference Sequence: NM_001291625.1) within the KCNJ16 
gene (unpublished data). 
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This mutation leads to the missense mutation p.Arg35Gln (R35Q) in Kir5.1 (UniProt: 
Q9NPI9), replacing the charged aliphatic arginine (R) by the neutral and polar amino acid 
glutamine (Q). This mutation is located in the N-terminal region of the protein (Figure 5).  
Since computer predictions (PolyPhen2; http://genetics.bwh.harvard.edu/pph2/index.shtml) 
suggested a devastation effect of the mutation on channel function we hypothesized that 
Kir5.1R35Q might be causative for the patient’s symptoms and might lead to impaired 
functionality of the DCT.16,30,33 
5.2.1 Electrophysiological characterization of the Kir5.1R35Q mutation 
In our Chinese hamster ovary (CHO) cell heterologous expression system, the mutation 
R35Q did not seem to change the subcellular localization of the protein. However, also in 
the case of the wildtype Kir5.1 protein the vast majority of the protein was found in the 
endoplasmic reticulum of CHO cells, even when coexpressed with Kir4.1. Therefore, 
immunofluorescence was not sensitive enough to assess a possible impairment of 
membrane trafficking (Figure 11). To understand the nature of the Kir5.1R35Q mutation, patch 
clamp recordings of HEK and CHO cells were performed. Since Kir5.1 alone does not 
produce functional homomeric channels in most expression systems, cells were always co-
transfected with Kir4.1. Whole cell measurements of CHO cells transfected with Kir4.1-
Kir5.1wt or Kir4.1-Kir5.1R35Q exhibited similar membrane potentials close to the equilibrium 
potential of K+ suggesting normal K+-conductance of the Kir5.1R35Q mutant (Figure 12 A, B 
and 13 C and E). Application of Ba2+ led to a strong depolarization attributed to inhibition of 
Ba2+-sensitive K+ channels. This Ba2+ effect was not observed in non-transfected cells 
indicating that K+ channels were successfully formed in cells transfected with Kir channels 
(Figure 12 C). However, no differences in Ba2+-sensitive currents were observed in Kir4.1-
Kir5.1wt and Kir4.1-Kir5.1R35Q expressing cells. Additionally, the observed inwardly rectifying 
single channel conductance of ~56 pS for Kir4.1-Kir5.1wt and for Kir4.1-Kir5.1R35Q were in 
line with previously reported conductances for heteromeric Kir4.1-Kir5.1 channels arguing 
against a loss-of-function of the Kir5.1R35Q mutant.50,51,56,80  
To confirm that the currents obtained were in fact the result of heteromeric channel 
formation and not contamination of homomeric Kir4.1 channels, single channel 
measurements in the cell-attached mode were performed using HEK cells. Cells transfected 
with homomeric Kir4.1 displayed a conductance of only ~30 pS (Figure 14 A). In contrast, 
Kir4.1-Kir5.1wt heteromers showed a conductance of ~56 pS, almost double of that obtained 
for homomeric Kir4.1. Additionally, Kir4.1-Kir5.1wt recordings displayed the characteristic 
Kir4.1-Kir5.1 channel sub-states, which is in agreement with the formation of Kir4.1-Kir5.1 
heteromeric channels even when the Kir5.1 is mutated (Figure 14 B and 15 A).51,56 Analysis 
Discussion 
-74- 
 
of the open probability also revealed no difference between the Kir4.1-Kir5.1wt or Kir4.1-
Kir5.1R35Q expressing cells. 
In addition to the recordings in the cell-attached configuration, inside-out measurements 
were performed to investigate a potential different pH sensitivity of Kir4.1-Kir5.1R35Q 
heteromers (Figure 16). However, both heteromers were similarly inhibited by intracellular 
pH arguing against a grossly altered pH sensitivity of the Kir4.1-Kir5.1R35Q heteromer. 
In summary, the performed electrophysiological characterization of Kir5.1R35Q revealed 1. 
No abnormal channel assembly with Kir4.1, 2. Unaltered conductance of the Kir4.1-
Kir5.1R35Q heteromers, 3. Unchanged open probabilities of the Kir4.1-Kir5.1R35Q heteromers, 
and 4. Preserved intracellular pH sensitivity of the Kir4.1-Kir5.1R35Q heteromers when 
compared to Kir4.1-Kir5.1wt. These data argue against a loss-of-function effect of the 
Kir5.1R35Q mutant and further studies are needed to understand if and how the mutation 
affects the functional properties of the Kir5.1 protein. Apparently, the Kir5.1R35Q variant is 
still able to interact with Kir4.1 in a normal way and to form heteromeric channels similar to 
wildtype Kir5.1. It is, however, still possible that the Kir5.1 R35Q variant differs from the 
wildtype with regard to the efficiency of this interaction (reduced efficiency due to 
overexpression) or other aspects, e.g. interaction with Kir4.2. In the distal convoluted 
tubules, however, Kir4.1-Kir5.1 are considered the most relevant basolateral K+ 
conductance. 
5.2.2 Kir5.1-mediated K+ sensing in DCT 
The distal convoluted tubule is a metabolically highly active nephron segment and plays a 
key role in Na+, K+ and divalent cations homeostasis. The symptoms of the Kir5.1 knockout 
mouse and our own expression analysis suggested that Kir5.1 might control DCT function 
in combination with Kir4.1. Studies with mutated Kir4.1 showed that EAST-causing 
mutations are loss-of-function mutations that impair the function of the Kir4.1-Kir5.1 channel 
and, thereby, the basolateral recycling of K+ that is needed for high activity of the Na+/K+-
ATPase.16  
Unexpectedly, the genetic inactivation of Kir5.1 had the opposite effect: loss of Kir5.1 in 
mice resulted in an enhanced basolateral K+ conductance carried by homomeric Kir4.1 
channels.54 Apparently, a major function of Kir5.1 is to exert an inhibitory effect on Kir4.1 
and to allow precise regulation of the heteromeric channels, e.g. by internal pH.54 In 
addition, recent studies proposed that the DCT, besides fine-tuning of the salt reabsorption, 
might also be involved in sensing plasma K+ and indirectly regulating plasma K+ 
balance.18,26,48 Terker et al. suggested a molecular mechanism where the DCT senses and 
responds to changes in K+ balance via altering the membrane voltage thereby affecting 
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intracellular [Cl-] which in turn regulates the activity of the NCC via Cl--sensitive WNK and 
SPAK kinases (Figure 3).17 The identity of the molecular K+ sensor is thought to be Kir4.1, 
although it seems likely that Kir5.1 is also involved. 
Our electrophysiological analysis of the Kir5.1R35Q mutant suggested a normal interaction 
with Kir4.1. Given the absence of a pathological phenotype in our experiments with the 
Kir5.1R35Q variant, it appears likely that the variant is not causative of the renal phenotype 
of Prof. Konrad's patient. The patient's symptoms are probably caused by mutations in other 
genes, but we cannot fully exclude that some functional impairment of the Kir5.1R35Q was 
missed in our studies.  Although the Kir5.1R35Q variant appeared normal, the physiological 
relevance of Kir5.1 for K+ sensing in the DCT cells was still largely unknown. To address 
the question of Kir5.1 function in DCT cells and its ability to act as a K+ sensor, we isolated 
murine DCT tubules from control and Kir5.1-/- mice.  
The ability of DCT to sense varying basolateral K+ conditions were tested by superfusion 
with solution containing 1 mM K+ instead of 3.6 mM (Figure 26). Superfusion of isolated 
DCTs with 1 mM K+ resulted in an increase in intracellular [Ca2+], even though the 
magnitude of the effect was small compared to superfusion with Ba2+ (Figure 28). The 
relative small effect size may be due to expression of calbindin in the DCT that binds and 
diffuses the Ca2+ ions to the basolateral membrane.12 The increased [Ca2+]i observed in 
isolated DCTs upon perfusion with 1 mM K+ might be due to a hyperpolarization of the 
basolateral membrane potential as hypothesized by Weinstein and co-workers.26,81 This 
hyperpolarization of the basolateral membrane would increase transepithelial membrane 
potential and therefore the driving force for an influx of Ca2+. However, the change in 
transepithelial membrane potential seems independent of Kir5.1 because even in the 
absence of Kir5.1, similar increases in intracellular Ca2+ signals were observed in response 
to low K+ suggesting that the absence of Kir5.1 did not alter the ability of the DCT to sense 
low K+ conditions (Figure 26 B and D). 
To further test if basolateral K+ channels are indeed K+ sensors, the reversible K+ channel 
inhibitor Ba2+ was used. After superfusing Ba2+, there was an increase in fura-2 signals 
(Figure 28). This result was unexpected and may result from Ba2+ entering the cells and 
mimicking intracellular Ca2+ consequently elevating fura-2 signals. As reported previously, 
Ba2+ and Ca2+ may enter the cytosol through the same pathway.26,70,78 Nonetheless, Ba2+ 
prevented the low K+-induced rise in intracellular Ca2+ (Figure 29) suggesting that Ba2+-
sensitive K+ channels are indeed K+ sensors in the DCT that help to translate varying 
external K+ levels into intracellular Ca2+ signals. 
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Since basolateral superfusion of tubules with 1 mM K+ might also affect apical K+ levels, we 
tested the specificity of K+ sensing by apical perfusion of the tubule with low K+ solution (LK) 
while keeping the basolateral solution constant. Interestingly, apical perfusion of DCTs with 
LK solution did not affect the Ca2+ levels (Figure 30). This response was unexpected since 
low K+ on the apical side probably leads to hyperpolarization of the apical membrane which 
would increase the driving force for Ca2+ reabsorption via apical TRPV5 mediating Ca2+ 
transport. Unfortunately, we could not measure the apical membrane voltage directly. It is 
conceivable that i) the apical membrane did not sufficiently hyperpolarized at low K+ solution 
(e.g. due to rather low K+ conductance compared to the basolateral channels or due to 
strong inward rectification of the apical K+ conductance); or ii) that the Ca2+ increase 
observed at low basolateral K+ concentrations is caused by store release or basolateral net 
Ca2+ influx.2,13,82 
In summary, our results disclosed that only decreasing K+ on the basolateral side leads to 
increased Ca2+ levels. Additionally, Kir5.1 seems to have no effect on the K+ sensing 
properties of the DCT, at least with regard to its Ca2+ increasing effect. In its role as a second 
messenger, changes of cytosolic Ca2+ in DCT cells may be consistent with the suggested 
theory of Terker et al. assuming that variations of extracellular K+ are sensed by DCT 
through changes of the membrane voltage.26 To further study this theory, 
electrophysiological measurements of membrane potential in DCT tubules are required. 
Additionally, our studies do not reveal as to whether the source of Ca2+ is intra- or 
extracellular, a question that needs to be addressed in future studies. 
5.3 Phenotype of Kir5.1-/- mice 
The symptoms of hypokalemia and hypermagnesuria present in the patient carrying the 
homozygous Kir5.1R35Q mutation suggested a renal involvement of Kir5.1 - although we 
were unable to find a functional deficit of this channel mutant in in vitro studies. In order to 
rule out limitations of our cellular model systems as cause of a missing phenotype and to 
gain further insights into the possible role of Kir5.1 in the kidney, we investigated the renal 
phenotype of a Kir5.1-/- mouse model. 
5.3.1 Electrolyte balance in Kir5.1-/- mice 
Paulais and co-workers published a Kir5.1-/- mouse model in a C57Bl/6 background.54 They 
found a Kir5.1-/- phenotype that besides hypokalemia was the opposite of the symptoms in 
EAST syndrome: hyperchloremic metabolic acidosis, hypercalciuria and hypermagnesuria 
(for comparison of biological parameters refer to Table 5).16,25,30,33,52,54 We analyzed our own 
Kir5.1-/- mice (also in C57Bl/6 background) to compare our findings with those observed by 
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Paulais and co-workers. In accordance with previous studies, Kir5.1-/- mice displayed 
hypokalemia and hypermagnesuria (Figure 17). Strikingly, we did not observe an acidosis 
as presented by Paulais, which might be due to the significantly reduced pCO2 levels 
(Figure 22 E) that suggests respiratory compensation of the acidosis. 
Table 5. Comparison of biological parameters of patients with mutated Kir4.1 (resulting in 
EAST/SeSAME syndrome), the patient with mutated Kir5.1R35Q, Kir4.1-/- and Kir5.1-/- mice 
models compared to their respective controls. 
Parameters are indicated as normal, elevated (↑) or reduced (↓) compared to their respective 
controls. Abbreviations: n. a., not available, n. d., not determined. 
 
Patients 
with EAST 
(mutated 
Kir4.1-/-)33 
Kir4.1-/- 
mice83 
Patient 
with 
Kir5.1R35Q 
(unpublished 
data) 
Kir5.1-/- 
mice (Paulais 
et al)
54 
Kir5.1-/- 
mice (own 
data) 
Plasma      
Na+ normal normal n. a. normal ↓ 
Cl- ↓ n. a. n. a. ↑ n. d. 
K+ ↓ ↓ ↓ ↓ ↓ 
Ca2+ normal normal ↓ normal ↓ 
Mg2+ ↓ (↓) ↓ normal normal 
Renin 
system 
renin ↑ 
normal 
aldosterone 
n. a. 
normal 
aldosterone 
normal 
aldosterone69 
Blood      
pH alkalosis (alkalosis) acidosis acidosis normal 
HCO3- ↑ ↑ n. a. ↓ normal 
pCO2 normal normal n. a. normal ↓ 
Urine      
Osmolality normal ↓ n. a. ↓ normal 
Na+ (↓) ↓ n. a. normal normal 
Cl- n. a. ↓ n. a. normal normal 
K+ ↑ ↓ n. a. ↑ ↑ 
Ca2+ ↓ normal n. a. ↑ normal 
Mg2+ ↑ normal n. a. ↑ ↑ 
NH4+ n a. ↑ n. a. normal normal 
Paulais and co-workers suggested that the Kir5.1-/- phenotype was due to enhanced 
function of the DCT as short-term treatment of the mice with the NCC inhibitor 
hydrochlorothiazide resulted in rectified hypercalciuria but increased Na+ excretion of the 
Kir5.1-/- mice. 
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In summary, our Kir5.1-/- mice display hypokalemia and hypermagnesuria but no overt 
acidosis. The absence of acidosis in our mice might be the result of reduced pCO2 levels 
that compensate the acidosis. In agreement with the data obtained from Paulais, in Kir5.1-
/- we (published in the thesis of Evelyn Humberg) did not observe an activation of the renin–
angiotensin–aldosterone system (RAAS) suggesting that the renal phenotype is mild and 
compensation mechanisms do not require activation of the RAAS.54,69 The ENaC-mediated 
Na+ absorption in the amiloride-sensitive distal nephron appears to be normal in Kir5.1-/- 
mice; however, there might be a slight (not significant) increase in amiloride-sensitive K+ 
excretion (Figure 18). Paulais et al.54 concluded from their results that NaCl reabsorption is 
increased in Kir5.1-/- mice. Under such conditions, distal Na+ delivery would be reduced and, 
as a consequence, K+ secretion would be rather decreased but not increased. Our results 
indicate that amiloride-sensitive K+ secretion is not impaired but rather increased suggesting 
that K+ secretion in the distal nephron likely contributes to the hypokalemia phenotype. It is, 
however, conceivable that also more proximal parts of the nephron contribute to the renal 
K+ loss, e.g. the proximal tubule, which is known to express Kir5.1. Future studies will be 
needed to address the function of Kir5.1 in proximal tubules. 
5.3.2 Effect of high Na+ diet in Kir5.1-/- mice 
Besides the physiological role of Kir5.1-/- in electrolyte homeostasis, other studies by Palygin 
et al. suggested an essential role of Kir5.1 in the pathophysiology of hypertension. It is well 
recognized that higher levels of Na+ intake are associated with elevated blood 
pressure.74,84,85 Importantly, the effect of dietary Na+ on blood pressure is dependent on 
other components of the diet and, specifically, its K+ content.86 Since both Kir4.1 and Kir5.1 
seem to regulate K+ homeostasis, the role of Kir5.1 in the development of hypertension was 
investigated by Palygin and co-workers. They created a Dahl salt-sensitive Kir5.1 deficient 
rat model that exhibited a renal phenotype reminiscent of SeSAME/EAST and Kir4.1 
deletion: salt wasting, hypomagnesemia, and hypokalemia.74 
Interestingly, the absence of Kir5.1 resulted in prominent retention of Kir4.1 in the cytosol 
of DCTs suggesting improper translocation of Kir4.1 in the absence of Kir5.1 in rats. This is 
the opposite of the marked upregulation of plasma membrane Kir4.1 in normotensive mice 
lacking Kir5.1.54 To determine whether improper Kir4.1 translocation is a common feature 
in hypertension or whether it is a feature only found in rat models, we induced hypertension 
in Kir5.1-/- mice by feeding a high Na+ (HNa) diet, which was commonly used to induce 
hypertension in C57BL6/J mice.75,76 The HNa diet was fed for two weeks and blood and 
urine samples were taken in regular intervals. 
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As expected, the HNa diet resulted in massively increased excretion of Na+ and Cl- in control 
and Kir5.1-/- mice (Figure 20 and 21). All other electrolytes were also significantly elevated, 
which is likely due to the different composition of the standard diet and the HNa diet. 
However, Kir5.1-/- mice did always wasted significantly more electrolytes when compared 
to control animals, an effect that was only partially seen before the start of the diet. Beside 
the loss of Na+, K+, Mg2+, Ca2+ and NH4+, the HNa diet also unmasked an impaired handling 
of Cl-, phosphate and sulfate in Kir5.1-/- mice (Figure 32). Since the main site for phosphate 
and sulfate reabsorption is the proximal tubule these data suggests that Kir5.1 is involved 
in proximal tubular function. 
Interestingly, control animals developed a respiratory alkalosis with reduced pCO2 but 
unaltered HCO3- levels after feeding of HNa diet. This effect was not seen in Kir5.1-/- 
animals. Contrary, the blood pH remained unaltered but pCO2 levels and HCO3- levels 
significantly increased after HNa diet (Figure 22). The animals also presented a more 
positive base excess, low pCO2 levels and higher pH which suggests that Kir5.1+/+ mice 
develop respiratory alkalosis in response to the high Na+ diet. At present, we have no 
conclusive explanation for the pronounced salt-wasting during the high Na+ diet. It appears 
as if the inactivation of Kir5.1 led to an impaired ability to adapt properly to high salt intake. 
Future studies will be necessary to corroborate these findings and to measure blood 
pressure under high salt diet (which we have not yet done to avoid interference of blood 
pressure measurements with renal salt excretion due to increased stress levels). The high 
salt diet experiments also suggest that the clinical symptoms of patients might be 
substantially influenced by dietary salt intake. 
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Figure 32. Comparison of urinary excretion of control (white and grey) and Kir5.1-/- (black and 
yellow) mice under standard diet and high Na+ diet. 
A high Na+ diet (HNa) did result in elevation of Cl-, Na+ and K+ excretion in both control and Kir5.1-/- 
mice.  
5.3.2 Role of KCNJ16 in respiration 
To comprehend the nature of the mechanisms of compensation exhibited by Kir5.1-/- mice 
plethysmography studies were performed. Kir5.1 and Kir4.1 are expressed in some of the 
areas involved in chemoreception such as the brainstem and peripheral 
chemoreceptors.39,62,87 It was suggested that Kir5.1 contributes to the chemosensory control 
of breathing.60,61,88 Besides, heteromeric Kir4.1-Kir5.1 channels have characteristics that 
potentially allow some sort of chemosensitivity, in particular the inhibition by intracellular 
acidification.53,55,57 
Contribution of Kir5.1 to the control of breathing was assessed by plethysmography studies 
under hypoxia and hypercapnia conditions. Ventilatory responses under normal conditions 
were similar in both groups of animals. In response to hypoxia, the Kir5.1-/- mice increased 
their depth of breathing and minute ventilation in a similar way like Kir5.1+/+ animals (Figure 
23). And also under hypercapnia conditions, the stimulation of respiration was similar in 
both genotypes (Figure 24). 
Thus, the physiological regulation of respiration was preserved in our Kir5.1-/- mice 
suggesting that Kir5.1 does not have an indispensable role for chemoreception. Since 
several other K+ channels are expressed in central and peripheral chemoreceptors, it is 
likely that those conductances compensate for the loss of Kir5.1.60 
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Taken together, the data presented here suggest that Kir5.1 is required for the fine-tuning 
of renal salt excretion and pH homeostasis. Genetic inactivation of Kir5.1 causes 
hypokalemia and results in the propensity to develop metabolic acidosis, hypomagnesemia 
and hypocalcemia. The phenotypes of Kir5.1 knockout mouse models mimic at least to 
some extent the clinical symptoms of a patient homozygous for R35Q, a rare missense 
variation of Kir5.1. However, in heterologous expression system, the R35Q mutant of Kir5.1 
produced normal channel currents indicating that this variant is at least not a complete loss-
of-function mutant. Further studies and the data from additional patients are required to 
decipher the precise role of Kir5.1 in the kidney and its possible role for human diseases.   
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6. Summary 
In the kidney, inwardly rectifying K+ channels of the Kir (KCNJ) family are essential for the 
control of salt transport. In the basolateral membrane of distal convoluted tubules (DCT), 
Kir4.1 (KCNJ10) together with Kir5.1 (KCNJ16) appears to be relevant for salt transport and 
adaptation of DCT to plasma K+ levels, so called K+ sensing. Loss-of-function mutations in 
KCNJ10 are known to result in EAST/SeSAME syndrome, a complex disorder with a renal 
salt wasting tubulopathy and alkalosis. Also for Kir5.1 a role in renal transport is likely: 
Paulais et al. observed hypokalemia, acidosis and hypercalciuria in a Kir5.1-/- mouse model 
and our collaborator Prof. Konrad identified in a patient with hypokalemia and acidosis a 
homozygous mutation of Kir5.1 (R35Q).  
We hypothesized that the mutation R35Q leads to impaired channel function and disturbed 
salt transport in the kidney, especially in the DCT. To address this question, I characterized 
the mutant Kir5.1 channel and studied the phenotype of Kir5.1-/- mice.  
The effect of the Kir5.1R35Q mutant on protein function was analyzed using 
immunofluorescence and patch-clamp experiments. Although computer algorithms had 
predicted a functional deficit, I found the conductance of cells transfected with Kir4.1-
Kir5.1R35Q heteromers unaltered compared to Kir4.1-Kir5.1wt. Also on the single channel 
level, the properties of the Kir5.1R35Q mutant were normal and the subcellular localization 
appeared unaltered. Taken together, the function of the Kir5.1R35Q mutant seems at least 
largely preserved or normal. However, smaller functional deficits or modified channel 
regulation might still have escaped our notice. 
To gain further insights into the role of Kir5.1 in the kidney, I investigated the renal 
phenotype of another Kir5.1-/- mouse model (not identical to the one of Paulais et al.). Using 
sorted tubules, I observed high Kir5.1 mRNA expression in DCT and in proximal tubules. 
Analysis of the Kir5.1-/- mice corroborated the hypokalemia phenotype, but the acidosis 
appeared compensated. Kir5.1-/- mice displayed a pathologically increased renal salt loss 
when fed a high NaCl diet pointing to a reduced capacity to adapt to dietary salt intake. To 
elucidate the role of Kir5.1 for K+ sensing in the DCT, isolated DCTs were exposed to 
changes of basolateral and apical K+. Fura-2 measurements revealed that only basolateral, 
but not apical, application of low K+* solution increased intracellular Ca2+ levels. However, 
deletion of Kir5.1 did not alter the Ca2+ signals suggesting that Kir5.1 channels are not 
essential for this component of the K+ sensing mechanism.  
 
Taken together, this study provided evidence that the rare Kir5.1 variant R35Q is probably 
not (or not alone) causative for acidosis and hypokalemia observed in a single patient 
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carrying this mutation. Nevertheless, our Kir5.1 knockout showed similar symptoms. 
Clearly, the role of Kir5.1 in the kidney is very complex and still incompletely understood. 
Further studies and the data from additional patients are required to decipher the precise 
role of Kir5.1 in the kidney and its possible role for human diseases.
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7. Zusammenfassung 
In der Niere spielen die einwärtsgleichrichtenden K+-Kanäle Kir4.1 (KCNJ10) und Kir5.1 
(KCNJ16) eine wichtige Rolle. In der basolateralen Membran des distalen Konvoluts (DCT) 
sind Kir4.1/Kir5.1-Kanäle entscheidend für den Salztransport und die Anpassung des 
Transports an das Plasma-K+, das so genannte “K+ Sensing”. Mutationen von KCNJ10 
führen zum EAST/SeSAME-Syndrom, einem komplexen Krankheitsbild mit renalem 
Salzverlust und Alkalose. Auch Kir5.1 soll eine Rolle in der Niere haben: Paulais et al. 
beobachteten Hypokaliämie, Azidose und Hyperkalziurie in einer Kir5.1-/--Maus und unser 
Kooperationspartner Prof. Konrad identifizierte in einem Patienten mit Hypokaliämie und 
Azidose eine homozygote Mutation von Kir5.1 (R35Q). 
Wir hypothetisierten daher, dass die R35Q-Mutation krankheitsverursachend sein könnte 
und insbesondere den Transport im DCT beeinträchtigt. Um diese Frage zu klären, habe 
ich daher die R35Q-Mutante charakterisiert und den Phänotyp der Kir5.1-/--Maus 
untersucht. 
Die Auswirkungen der Mutation habe ich mittels Immunfluoreszenz und Patch-Clamp 
untersucht. Obwohl Computeralgorithmen einen Funktionsdefekt vorhersagten, war die 
Leitfähigkeit von Zellen, die mit Kir4.1/Kir5.1R35Q transfiziert waren, ähnlich denen von 
Zellen mit Wildtypkanälen. Auch auf der Einzelkanalebene war kein Funktionsdefekt 
nachweisbar und die subzelluläre Lokalisation erschien unverändert. Zusammengefasst 
war die Funktion der R35Q-Mutante scheinbar normal oder zumindest weitgehend erhalten. 
Jedoch ist es denkbar, dass uns kleinere Funktionsdefekte oder eine veränderte Regulation 
entgangen sind. 
Um weitere Einblicke in die Rolle von Kir5.1 in der Niere zu erhalten, habe ich den Phänotyp 
eines von Paulais et al. unabhängigen Kir5.1-Knockoutmausmodells untersucht. Mittels 
sortierter Tubulussegmente beobachtete ich eine starke Kir5.1 mRNA-Expression im DCT 
und im proximalen Tubulus. Untersuchungen an der Knockoutmaus bestätigten die 
Hypokaliämie, die Azidose erschien jedoch kompensiert. Kir5.1-/--Mäuse zeigten einen 
pathologisch verstärkten renalen Salzverlust unter einer hoch-NaCl-Diät, was für eine 
beeinträchtige Fähigkeit zur Anpassung an die diätetische Salzaufnahme spricht. Um die 
Rolle von Kir5.1 für das „K+ Sensing“ im DCT zu untersuchen, wurden isolierte DCTs 
veränderten K+ Konzentrationen auf der basolateralen oder apikalen Seite ausgesetzt. 
Fura-2-Messungen zeigten, dass nur die basolaterale, nicht aber apikale Erniedrigung des 
K+ zu einem intrazellulären Ca2+-Anstieg führte. Jedoch war dieses Ca2+-Signal unabhängig 
von der Anwesenheit von Kir5.1, was darauf hinweist, dass Kir5.1 bei dieser Komponente 
des „K+ Sensings“ keine Rolle spielt. 
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Zusammengefasst liefert diese Studie Hinweise, dass die seltene Kir5.1-Variante R35Q 
vermutlich nicht (oder nicht alleine) für die Azidose und die Hypokaliämie des einzelnen 
Patienten verantwortlich ist. Nichtsdestotrotz zeigten unsere Kir5.1-Knockoutmäuse einen 
ähnlichen Phänotyp. Ganz offensichtlich ist die Rolle von Kir5.1 in der Niere sehr komplex 
und noch immer nur unvollständig verstanden. Weitere Studien und zusätzliche 
Patientendaten werden nötig sein, um die genaue Funktion von Kir5.1 in der Niere und 
seine Bedeutung für menschliche Erkrankungen zu klären. 
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9. Supplements 
 
Figure S1. Relative expression of tubule markers. 
Relative expression of tubule markers (A) podocin (glomeruli), (B) megalin (PT), (C) NKCC2 (TAL), 
(D) calbindin (DCT) and (E) mucolipin (CD) in sorted tubules to verify the correct sorting of each 
tubular segment. Abbreviations: Glom = glomeruli; PT = proximal tubule; TAL = thick ascending limb; 
DCT = distal convoluted tubule and CD = collecting duct. The numbers corresponds to the amount 
of idenpendent tubular preparations analyzed. Data is shown as mean±SEM. 
 
Figure S2. Effect of amiloride on normalized electrolyte excretion of Kir5.1+/+ and Kir5.1-/- mice. 
Electrolyte excretion of Kir5.1-/- (n = 19, ■) and control Kir5.1+/+ (n=20, □) mice. All ions concentration 
were normalized to creatinine concentration in urine and presented as [mM ion/mM creatinine]. 
Statistical analysis was performed with an unpaired Student’s t-test between the two groups or paired 
t-test between control and amiloride of each group. After Bonferroni corrections, p-values ≤ 0.006 
were accepted as significantly different. Phosphate and Ca2+ were significantly different in Ki5.1-/- 
mice, while Ca2+ was significantly different for Kir5.1+/+ between control and amiloride (paired t-test). 
Data was partially shown in Figure 18. 
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Figure S3. Effects of high salt diet on blood parameters of Kir5.1+/+ and Kir5.1-/-. 
(A) Hematocrit and (B) pO2 were analyzed by blood-gas analyzer of blood samples obtained from 
facial vein of conscious Kir5.1+/+ ( ) and Kir5.1-/- ( ) mice Data represents mean values ± SEM. 
Statistical analysis was performed with a paired Student’s t-test between before and after the diet for 
Kir5.1-/- and for Kir5.1+/+. In addition, to an unpaired Student’s t-test between Kir5.1-/- and Kir5.1+/+ (*, 
p≤0.05). 
Table S1. Normalized excretion of various electrolytes from Kir5.1+/+ and Kir5.1-/- mice under 
high Na+ diet. 
Electrolyte excretion of Kir5.1+/+ (n = 10) and Kir5.1-/- (n = 8) mice throughout the high salt diet. All 
ions concentrations were normalized to creatinine concentration in the urine and presented as [mM 
ion/mM creatinine]. Data represents mean±SEM. Statistical analysis was performed with unpaired 
Student’s t-test between the two groups with Bonferroni corrections (p-value≤0.006) was considered 
statistically significant. Data was partially shown in Figure 19. 
  
Cl- PO43- SO42- Na+ NH4+ K+ Mg2+ Ca2+ 
C
o
n
tr
o
l 
Mean Kir5.1-/- 72.9 13.0 17.0 38.3 39.3 134.4 21.7 3.8 
SEM 10.0 1.1 2.0 4.9 7.5 9.6 1.3 0.4 
Mean Kir5.1+/+ 50.1 10.0 12.5 21.6 14.9 90.2 11.1 1.1 
SEM 6.1 1.5 1.1 1.4 1.1 7.2 0.4 0.1 
p-value 0.10 0.15 0.10 0.01 0.02 0.004 ≤0.001 ≤0.001 
D
a
y
 3
 
Mean Kir5.1-/- 85.7 11.8 14.9 69.5 27.2 39.7 11.5 3.1 
SEM 21.1 0.9 1.7 14.7 5.5 6.1 1.4 0.5 
Mean Kir5.1+/+ 73.6 19.4 11.3 45.4 17.1 37.6 13.2 1.3 
SEM 15.7 2.1 2.2 7.7 2.6 9.0 1.1 0.2 
p-value 0.67 0.003 0.23 0.20 0.15 0.85 0.36 0.01 
D
a
y
 8
 
Mean Kir5.1-/- 448.4 29.8 29.0 292.8 62.1 131.5 16.1 2.7 
SEM 66.7 3.1 3.3 37.3 10.1 23.3 1.5 0.6 
Mean Kir5.1+/+ 181.3 12.4 15.4 129.3 24.3 39.2 9.9 0.9 
SEM 43.6 3.6 1.8 24.6 3.8 8.7 1.1 0.1 
p-value 0.007 0.003 0.005 0.004 0.006 0.004 0.005 0.015 
D
a
y
 1
6
 
Mean Kir5.1-/- 342.4 24.0 26.3 247.6 52.0 96.1 19.7 3.0 
SEM 84.7 4.4 4.7 49.8 10.6 23.5 2.2 0.4 
Mean Kir5.1+/+ 91.5 8.7 8.3 59.9 18.1 19.3 10.0 1.0 
SEM 22.9 1.7 1.7 14.5 3.5 6.7 1.1 0.1 
p-value 0.027 0.012 0.007 0.007 0.018 0.016 0.003 0.002 
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